Original Article
Outcome of Cord-Blood Transplantation from Related and Unrelated Donors
N Engl J Med 1997; 337:373-381August 7, 1997
- Abstract
Background
Cord-blood banks have increased the use of cord-blood transplantation in patients with hematologic disorders. We have established a registry containing information on the outcome of cord-blood transplantation.
Methods
We sent questionnaires to 45 transplantation centers for information on patients receiving cord-blood transplants from 1988 to 1996. Reports on 143 transplantations, performed at 45 centers, were studied, and the responses were analyzed separately according to whether the donor was related or unrelated to the recipient.
Results
Among 78 recipients of cord blood from related donors, the Kaplan–Meier estimate of survival at one year was 63 percent. Younger age, lower weight, transplants from HLA-identical donors, and cytomegalovirus-negative serologic results in the recipient were favorable prognostic factors. Graft-versus-host disease of at least grade II occurred at estimated rates of 9 percent in 60 recipients of HLA-matched cord blood and 50 percent in 18 recipients of HLA-mismatched cord blood. Neutrophil engraftment was associated with an age of less than six years (P = 0.02) and a weight of less than 20 kg (P = 0.02), and it occurred in 85 percent of patients receiving 37 million or more nucleated cells per kilogram of body weight. Among 65 patients who received cord blood from unrelated donors, the Kaplan–Meier estimate of survival at one year was 29 percent. Cytomegalovirus-negative serologic status in these recipients was associated with improved survival (P = 0.03) and was the most important predictor of graft-versus-host disease (P = 0.04). Neutrophil recovery occurred in 94 percent of the patients who received 37 million or more nucleated cells per kilogram from unrelated donors.
Conclusions
Cord blood is a feasible alternative source of hematopoietic stem cells for pediatric and some adult patients with major hematologic disorders, particularly if the donor and the recipient are related.
Media in This Article
Figure 1
Kaplan–Meier Estimates of the Probability of Survival (Panel A), Engraftment of Neutrophils (Panel B) and Platelets (Panel C) at Day 60, and Acute Graft-versus-Host Disease (GVHD) (Panel D), According to Whether the Cord-Blood Transplant Originated from a Related or an Unrelated Donor.Table 1
Characteristics of the Patients Receiving Cord-Blood Transplants.Article Activity
- Article
Since the first successful transplantation of umbilical-cord blood in a patient with Fanconi's anemia,1 cord blood has been used as a source of hematopoietic stem cells for transplantation to treat a variety of malignant and nonmalignant hematologic disorders.2-4 Cord-blood banks have developed worldwide.5-9 Eurocord, a group of physicians, was organized to standardize methods of collecting, testing, and cryopreserving cord blood from both related and unrelated donors; to study the properties of cord-blood cells; and to manage a registry of cord-blood transplantation performed in Europe.10 We analyzed 143 cord-blood transplantations performed from October 1, 1988, through December 31, 1996, at 45 centers.
Methods
Data Collection and Characteristics of Patients
Using the data bases of the European Blood and Marrow Transplantation Group and the French Society of Bone Marrow Transplantation, we invited centers that had reported performing cord-blood transplantation to join Eurocord. In addition, nine non-European centers volunteered to enter the study (see the Appendix). Overall, 45 centers reported from 1 to 22 cases each. Questions about the disease and the outcome of transplantation were already included in the questionnaire of the European Blood and Marrow Transplantation Group; questions concerning the origin of the cord blood, its processing, the number of cells collected and infused, HLA typing, and hematologic reconstitution were added by Eurocord. A clinical coordinator verified the accuracy of the data provided by the centers. Of 148 transplantations reported before December 31, 1996, 5 were excluded from the study because the patients had received bone marrow in addition to cord blood. Seventy-eight patients received cord blood from a related donor, and 65 received cord blood from an unrelated donor. These two groups were analyzed separately with respect to all study end points.
Conditioning and Prophylaxis against Graft-Versus-Host Disease
The conditioning regimens varied according to the patient's diagnosis, previous treatment, and disease status. Patients who received a cord-blood transplant from an HLA-identical sibling had the conditioning ordinarily given before bone marrow transplantation. Total-body irradiation combined with cyclophosphamide or other chemotherapy was used in 60 patients; busulfan was used instead of total-body irradiation in 40 patients (mean age, 4 years; range, 0.2 to 11) who received cord blood from a related donor and in 24 patients (mean age, 8 years; range, 0.3 to 28) who received cord blood from an unrelated donor. In 49 patients receiving an HLA-mismatched transplant, antithymocyte globulin or a monoclonal anti–T-cell antibody was given before transplantation. Cyclosporine, alone or combined with prednisone or methotrexate, was given as prophylaxis against graft-versus-host disease (GVHD). Established GVHD was usually treated with prednisone. Granulocyte colony-stimulating factor (G-CSF) or granulocyte–macrophage colony-stimulating factor (GM-CSF) was given to 104 patients (73 percent) after transplantation, at various times and in various doses.
Characteristics of Infused Cord Blood
The methods of collecting, cryopreserving, storing, and thawing cord blood varied among the centers. Usually, whole blood was cryopreserved in 10 percent dimethyl sulfoxide and thawed according to the method used at the cord-blood bank in New York.6,7 Cord blood was provided from cord-blood banks in New York (47 cases), Milan, Italy (14), Paris (11), Dusseldorf, Germany (6), and the vicinity of the center (65). The median volume collected was 99 ml (range, 37 to 360), the median number of nucleated cells was 1.08 billion (range, 130 million to 5.8 billion), the median number of CD34+ cells (in 31 cases) was 3.8 million (range, 0.02 million to 38 million), and the median number of granulocyte–macrophage colony-forming units (CFU-GM) (in 83 cases) was 440,000 (range, 1000 to 29.8 million). The properties of the cord blood collected from the related and the unrelated donors were similar. The median number of nucleated cells infused after thawing was 37 million per kilogram of body weight (range, 7 million to 300 million), the median number of CD34+ cells (in 67 cases) was 200,000 per kilogram (range, 0 to 4.5 million), and the median number of CFU-GM infused (in 104 cases) was 24,000 per kilogram (range, 0 to 2.2 million). HLA typing was performed by serologic testing in the case of class I HLA-A and HLA-B antigens and by low-resolution generic oligotyping in the case of DRB1. Among the 78 cord-blood transplantations from related donors, there were no mismatches in 60 (the donor was an HLA-identical sibling) and there were mismatches of one HLA antigen in 3, two antigens in 5, three antigens in 9, and four antigens in 1. Among the 65 transplantations from unrelated donors, there were no mismatches in 9, one mismatch in 43, two mismatches in 11, and three mismatches in 2.
End Points
Surrogate end points indicating engraftment were the times from transplantation to the recovery of neutrophil and platelet counts. Recovery of neutrophils was defined as the time needed to reach an absolute neutrophil count of at least 500 per cubic millimeter on three consecutive days. Failure of engraftment was defined by the absence of detectable engraftment at day 60, a second transplantation, or hematopoietic reconstitution with autologous cells (that is, the reappearance of cells with markers bearing the recipient's sex, ABO type, or HLA-antigen status). Platelet recovery was defined as the time needed to reach a sustained platelet count of at least 20,000 per cubic millimeter in the absence of platelet transfusions. Graft rejection was defined as engraftment followed by pancytopenia or GVHD without signs of myeloid engraftment. Data on patients in whom no engraftment occurred were censored if the patient died before day 60. Acute GVHD was scored on the basis of standard criteria.11 Grades 0 and I GVHD were not counted as acute GVHD. In patients surviving more than 100 days, cases of GVHD were defined as chronic and coded as either limited or extensive.12 Relapses, complications, and causes of death were also reported.
Statistical Analysis
Our findings are presented as of January 1, 1997, with regard to overall survival, and as of March 31, 1997, with regard to engraftment and GVHD. All data on the time to failure were calculated from the date of cord-blood transplantation to the date of the event (engraftment, acute GVHD, or death) and were estimated by the Kaplan–Meier method. The prognostic significance of base-line covariates was studied by two-sided log-rank tests. All variables found to have a P value of less than 0.10 by that test were included as binary covariates in a Cox proportional-hazards model, with the use of a stepwise procedure with a type I error of 0.05. Relative risks for the association between covariates and events were estimated with 95 percent confidence intervals. SAS software (SAS Institute, Cary, N.C.) was used.
Results
Characteristics of the Patients
Table 1Table 1
Characteristics of the Patients Receiving Cord-Blood Transplants. shows the characteristics of the patients before transplantation. Of the 78 related donors of cord blood, 76 were siblings of the recipient, 1 was a cousin, and 1 was a child donating cord blood to the mother. Of the 143 recipients, 95 received transplants to treat hematologic cancers, 26 had a bone marrow failure syndrome, 8 had hemoglobinopathy, and 14 had some other type of genetic disease. Of 62 patients with acute leukemia, 37 received transplants during a first or second complete remission and 25 were in a more advanced stage; 10 had previously received a bone marrow transplant (autologous in 9 and allogeneic in 1).Overall Results
The overall survival at one year for all 143 patients was 49 percent (Kaplan–Meier estimate) (Table 2Table 2
Factors Associated with Survival after Cord-Blood Transplantation.). For recipients of cord blood from related donors, one-year survival was 63 percent, and for recipients of cord blood from unrelated donors, it was 29 percent (P<0.001 by the log-rank test) (Figure 1AFigure 1Kaplan–Meier Estimates of the Probability of Survival (Panel A), Engraftment of Neutrophils (Panel B) and Platelets (Panel C) at Day 60, and Acute Graft-versus-Host Disease (GVHD) (Panel D), According to Whether the Cord-Blood Transplant Originated from a Related or an Unrelated Donor.). In all 143 patients, variables associated with better survival were an age of less than six years (P<0.001 by the log-rank test), weight of less than 20 kg (P<0.001), infusion of at least 37 million nucleated cells per kilogram (P = 0.04), HLA identity with the donor (P<0.001), and cytomegalovirus-negative serologic status in the recipient (P<0.001). Because the outcomes in recipients of cord blood differed considerably according to whether the donor was related or unrelated, we decided to analyze the two types of transplantations separately.Survival
Among recipients of cord blood from related donors, overall survival at one year was 63 percent (Kaplan–Meier estimate) (Table 2), and the median duration of follow-up was 29 months (range, 1 month to 8 years). Overall survival at one year was 73 percent in recipients of HLA-matched cord blood and 33 percent in recipients of cord blood mismatched for one or more HLA antigens (P = 0.006). Variables associated with better survival were an age of less than six years, weight of less than 20 kg, cytomegalovirus-negative serologic status in the recipient, and HLA identity with the donor (Table 2). From the Cox model we found that the most favorable factors for survival were weight of less than 20 kg (relative risk, 0.24; 95 percent confidence interval, 0.11 to 0.52; P<0.001) and cytomegalovirus-negative serologic status in the recipient (relative risk, 0.41; 95 percent confidence interval, 0.18 to 0.90; P = 0.02).
Among recipients of cord blood from unrelated donors, the Kaplan–Meier estimate of survival at 1 year was 29 percent, and the median duration of follow-up was 10 months (range, 1 to 30). The number of HLA mismatches between the donor and the recipient did not influence the survival rate, probably because we did not use high-resolution molecular typing for class I and class II antigens. As compared with cytomegalovirus-positive serologic status in the recipient, cytomegalovirus-negative status was associated with longer survival (median, 72 vs. 295 days; P = 0.03). Patients who received less than 37 million nucleated cells per kilogram had 22 percent survival at one year, whereas those who received at least 37 million nucleated cells per kilogram had 41 percent survival at one year (P = 0.07).
Engraftment
Among all 143 patients, the median time needed to reach an absolute neutrophil count of at least 500 per cubic millimeter was 30 days (range, 8 to 56), and to reach a platelet count of at least 20,000 per cubic millimeter the median time was 56 days (range, 9 to 180). The probability of an absolute neutrophil count of at least 500 per cubic millimeter by day 60 after transplantation was 79 percent in recipients of cord blood from related donors and 87 percent in recipients of cord blood from unrelated donors (Table 3Table 3
Factors Associated with Neutrophil Engraftment within 60 Days after Cord-Blood Transplantation. and Figure 1B). For platelets, the respective probabilities were 62 percent and 39 percent (Table 4Table 4
Factors Associated with Platelet Engraftment within 60 Days after Cord-Blood Transplantation. and Figure 1C).Among the 78 patients who received cord blood from related donors, 46 had cancer. Data on four of these patients were censored, and in seven the cord blood did not engraft (three later received autologous bone marrow transplants, one had reconstitution of hematopoiesis with his own cells obtained before transplantation, and three died with aplastic bone marrow). Among the 17 patients with bone marrow failure syndrome, 3 had censored data and in 3 the cord blood did not engraft (2 received second transplants, and 1 had aplastic bone marrow at the time of death). Five of eight patients with Fanconi's anemia remained alive, with signs that the transplanted cord blood had engrafted. Among eight patients with hemoglobinopathy, four had engraftment and four did not (of the latter, two received a second bone marrow transplant and two patients had hematopoietic reconstitution with their own cells obtained before transplantation). Among the seven patients with inborn metabolic errors, there was engraftment in five, data on one were censored, and in one the transplant did not engraft.
Among the 65 recipients of cord blood from unrelated donors, 49 had cancer, 7 had censored data, and in 5 the cord blood did not engraft (3 received second transplants, 1 had reconstitution of his own hematopoietic cells, and 1 had graft rejection). Among the nine patients with bone marrow failure syndrome, four of eight with Fanconi's anemia had censored data, engraftment did not occur in one (who died after a second cord-blood transplantation), and one is alive. Of seven patients with inborn metabolic errors, two had censored data and the transplant failed to engraft in one.
The factors associated with engraftment (as judged on the basis of the absolute neutrophil count and the platelet count 60 days after cord-blood transplantation) are shown in Table 3 and Table 4. In the entire group, neutrophil engraftment was associated with the infusion of at least 37 million nucleated cells per kilogram, as compared with less than 37 million nucleated cells per kilogram (P = 0.001) (Table 3); platelet engraftment was associated with a weight of at least 20 kg in the recipient (P = 0.02), and with HLA identity as compared with any HLA mismatch (P<0.001) (Table 4). Among the recipients of cord blood from related donors, neutrophil engraftment was influenced by age (P = 0.02), weight (P = 0.02), and the number of nucleated cells infused per kilogram (P = 0.06). In the Cox proportional-hazards analysis, an age of less than six years was associated with a higher likelihood of reaching an absolute neutrophil count of more than 500 per cubic millimeter before day 60 (relative risk, 0.5; 95 percent confidence interval, 0.2 to 0.9; P = 0.008). For platelet recovery, the most important factor was HLA identity between the donor and the recipient (P< 0.001). Among the recipients of cord blood from unrelated donors, recovery of the absolute neutrophil count and platelet engraftment were also associated with a higher number of nucleated cells infused per kilogram and with HLA identity.
GVHD
Figure 1D shows the probability of acute GVHD among the recipients of cord blood from related and unrelated donors. Among the recipients of cord blood from related donors, acute GVHD of at least grade II was observed in 14 patients (grade II in 10, grade III in 3, and grade IV in 1). Chronic GVHD was observed in 8 of 56 patients who survived more than 100 days. Among the 65 recipients of cord blood from unrelated donors, acute GVHD was observed in 21 (grade II in 8, grade III in 9, and grade IV in 4). Among the 23 patients who survived more than 100 days, none had chronic GVHD. The factors associated with an increased risk of acute GVHD are shown in Table 5Table 5
Factors Associated with Acute Graft-versus-Host Disease after Cord-Blood Transplantation.. Among patients who received cord-blood transplants from related donors, the number of HLA mismatches with the donor was the most important factor; the estimated incidence of acute GVHD was 9 percent in recipients of HLA-identical cord blood from related donors and 50 percent in recipients of HLA-mismatched cord blood from related donors (P<0.001). In the Cox proportional-hazards analysis, HLA mismatching was the only factor that was associated with an increased risk of GVHD (relative risk, 7.7; 95 percent confidence interval, 2.5 to 23; P<0.001).In recipients of cord blood from unrelated donors, the incidence of acute GVHD was not affected by the number of HLA mismatches. Cytomegalovirus-negative serologic status was associated with a lower risk of acute GVHD than was cytomegalovirus-positive status (P = 0.04).
Other Complications, Relapses of Leukemia, and Causes of Death
Relapses of the original cancer were observed in 22 of the 95 patients with cancer. Of the 46 patients who received cord-blood transplants from related donors to treat cancer, 10 of 38 who had leukemia relapsed (4 with acute myeloblastic leukemia, 5 with acute lymphoblastic leukemia, and 1 with chronic myeloid leukemia); 5 remained alive after a second bone marrow transplant or after donor lymphocyte transfusions, and 5 (2 with neuroblastoma and 3 with myelodysplastic syndrome) died of resistant disease. Of the 49 patients who received cord-blood transplants from unrelated donors to treat cancer, 7 relapsed (3 with acute myeloblastic leukemia, 3 with acute lymphoblastic leukemia, and 1 with chronic myeloid leukemia). Two of the seven remained alive after treatment.
Thirty of the 78 recipients of cord blood from related donors died; the primary causes of death were relapse in 11, rejection in 8, infection in 5, veno-occlusive liver disease in 2, GVHD in 1, cardiac failure in 1, and multiorgan failure in 2. Thirty-eight of the 65 patients who received cord blood from an unrelated donor died; the primary causes of death were relapse in 5, interstitial pneumonitis in 7, acute respiratory distress syndrome in 2, veno-occlusive liver disease in 3, cardiac failure in 2, GVHD in 4, rejection in 4, infection in 10, and hemorrhage in 1.
Discussion
The clinical advantages of cord blood as a source of allogeneic hematopoietic stem cells for transplantation may reflect differences between fetal and adult hematopoietic stem cells.13,14 As compared with hematopoietic stem cells from adults, hematopoietic stem cells in cord blood have distinctive proliferative advantages, including the capacity to form more colonies in culture, a higher cell-cycle rate, autocrine production of growth factors, and longer telomeres.15,16 All these properties should favor the engraftment and growth of cord-blood hematopoietic stem cells. Moreover, the relative immaturity of lymphocytes in cord blood may reduce the risk and severity of GVHD, which in turn could permit more HLA mismatching between donor and recipient than is usually acceptable with transplants of blood or marrow hematopoietic stem cells from adults.
Cord-blood banks have developed worldwide, and a considerable effort has been made to standardize banking procedures.6,7 There are several advantages to these banks, including the availability of hematopoietic stem cells, the low rate of viral infection at birth, and the possibility of collecting cord blood from ethnic groups not well represented in registries of bone marrow donors. There are potential legal and ethical problems, including the provision of informed consent and the follow-up of the donor to detect the possible transmission of genetic or infectious diseases.17-20
The limited number of nucleated cells in cord blood arouses concern about engraftment. In the 143 patients we studied, the median number of nucleated cells found in cord blood, whether it was obtained from related or unrelated donors, was 1.1 billion cells per unit. We found that the number of nucleated cells infused per kilogram was a major factor in the recovery of neutrophil and platelet counts. Among the recipients of cord blood from related donors, those who received less than 37 million nucleated cells per kilogram took a median of 35 days (range, 8 to 49) to reach an absolute neutrophil count of at least 500 cells per cubic millimeter and a median of 53 days (range, 16 to 180) to reach a platelet count of at least 20,000 per cubic millimeter. By contrast, among the patients who received 37 million or more nucleated cells per kilogram, the median time to neutrophil recovery was 25 days (range, 14 to 41) and the median time to platelet recovery was 45 days (range, 14 to 139). Recipients of cord blood from unrelated donors who received less than 37 million nucleated cells per kilogram took a median of 34 days (range, 14 to 48) to reach an absolute neutrophil count of at least 500 per cubic millimeter and a median of 134 days (range, 30 to 180) to reach a platelet count of at least 20,000 per cubic millimeter, whereas among the patients who received 37 million or more nucleated cells per kilogram, the median times were 25 days (range, 10 to 56) and 47 days (range, 9 to 85), respectively.
In a series of 25 children who received cord blood from unrelated donors, Kurtzberg et al. found a median dose of 30 million nucleated cells per kilogram (range, 7 million to 110 million).3 Among 22 of these patients the cord blood engrafted, with a median of 22 days needed to reach an absolute neutrophil count greater than 500 per cubic millimeter. All the patients received filgrastim (granulocyte colony-stimulating factor) to accelerate engraftment, however. The International Cord Blood Registry2 reported the results in 44 children who received cord-blood transplants from related and unrelated donors. The median number of nucleated cells infused was 52 million per kilogram (range, 10 million to 330 million). The median time to neutrophil recovery was 22 days, and the probability of engraftment was 0.82. There was no correlation among the number of cells infused, the use of hematopoietic growth factors, and engraftment. The same group reported results in 18 other patients; the median number of nucleated cells per kilogram was 41 million (range, 14 million to 400 million), and the cord blood engrafted in all 13 patients who survived for more than 30 days; it took a median of 24 days to reach an absolute neutrophil count of more than 500 per cubic millimeter. In the absence of prospective studies, it is difficult to recommend an optimal number of cells needed for long-term engraftment. Moreover, the cell dose is not the only factor associated with engraftment; we found that HLA mismatching between donor and recipient also increased the risk of delayed engraftment.
Cord-blood cells, which are immunologically immature, may decrease the incidence and severity of acute GVHD.21 As in previously published series, the GVHD we observed was not life-threatening, and the incidence of chronic GVHD was low. In the case of recipients of cord blood from related donors, the incidence of acute GVHD increased with the number of HLA mismatches. We cannot draw any conclusion about the role of HLA mismatches in recipients of cord blood from unrelated donors in the absence of high-resolution HLA typing, the importance of which has been shown in recent analyses of the transplantation of bone marrow from unrelated donors.22-24
This report shows that cord blood is an alternative source of hematopoietic stem cells for children and some adults with malignant and nonmalignant hematologic diseases. With other technical developments in hematopoietic-stem-cell transplantation, we may be able to identify a donor for any patient needing a transplant. This new situation calls for carefully planned prospective studies of the clinical efficacy of strategies of donor selection.
Supported by a grant (Eurocord BMH4CT96) from the Biomed II program of the European Union and by a grant from the European Blood and Marrow Transplantation Group.
Source Information
From the Hôpital Saint-Louis, Paris (E.G., V.R., A.B.-C., C.C.); the University of Pavia, Pavia, Italy (F.L.); the University La Sapienza, Rome (W.A.); the Hospital de Clinicas, Curitiba, Brazil (R.P.); the Hospital Infantil Vall d'Hebron, Barcelona, Spain (J.O.); the Hôpital Debrousse, Lyons, France (G.S.); the Hospital Albert Einstein, São Paulo, Brazil (E.F.); the Hôpital Saint-Antoine, Paris (J.-P.L.); and the Clinica Puerta de Hierro, Madrid (M.F.).
Address reprint requests to Dr. Gluckman at the Hematology Bone Marrow Transplant Unit, Hôpital Saint-Louis, 1 ave. Claude Vellefaux, 75475 Paris CEDEX 10, France.
The members of the Eurocord Study Group are listed in the Appendix.
Appendix
In addition to the authors, the following persons and institutions participated in this study:
Eurocord centers: M. Abecasis, Instituto Portugues Oncologia, Lisbon, Portugal; I. Badell Serra, Hospital Santa Creu i Santa Pau, Barcelona, Spain; M. Beksac, Ibni Sina Hospital, Ankara, Turkey; F. Bernaudin, Hôpital Henri-Mondor, Créteil, France; V. Bogdanic, University Hospital Center-Rebro, Zagreb, Croatia; A. Bosi, Ospedale di Carregi, Florence, Italy; J.Y. Cahn, Hôpital Jean Minjoz, Besançon, France; G. Cornu, University of Louvain, Brussels, Belgium; L.G. Delliers, University of Milan, Milan, Italy; I. Dokal, Hammersmith Hospital, London; C. Favre, University of Pisa, Pisa, Italy; A. Fisher, Hôpital Necker, Paris; B.E.S. Gibson, Royal Hospital for Sick Children, Glasgow, United Kingdom; J.P. Jouet, Hôpital Claude Huriez, Lille, France; A. Kinoshita, Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan; P. Kobylka, Institute of Hematology and Blood Transfusion, Prague, Czech Republic; P. Lutz, Hôpital Civil, Strasbourg, France; T. Masszi, St. Laszlo Hospital, Budapest, Hungary; J. Millone, Fundacion Mainetti, Cronnet, Argentina; V. Milovic, Antartida Hospital Privado, Buenos Aires, Argentina; R. Miniero, University of Turin Ospedale Regina Margherita, Turin, Italy; A. Nagler, Hadassah University Hospital, Jerusalem, Israel; A. Pension, Policlinico St. Orsola Malphighi, Bologna, Italy; J. Perez-Oyteza, Hospital Ramon y Cajal, Madrid, Spain; C. Peters, St. Anna Kinderspital, Vienna, Austria; E. Plouvier, Hôpital Saint-Jacques, Besançon, France; J. Reiffers, Hôpital du Haut Levêque, Pessac, France; I. Roberts, Hammersmith Hospital, London; S. Roittman, Hospital de Clinicas, Porto Alegre, Brazil; U. Saarinen, University of Helsinki, Helsinki, Finland; J. Stary, University Hospital Motol, Prague, Czech Republic; Y. Takaue, University of Tokushima, Tokushima, Japan; C. Urban, University Children's Hospital, Graz, Austria; P. Veys, Great Ormond Street Hospital for Children, London; E. Vilmer, Hôpital Robert Debré, Paris; J.M. Vossen, University Hospital Leiden, Leiden, the Netherlands; W. Jedrzejczack, Central Clinical Hospital, Warsaw, Poland; I. Yaniv, Children's Medical Center of Israel, Tel Aviv University, Petach-Tikva, Israel; and F. Zintl, University of Jena, Jena, Germany.
Cord-blood banks: M. Benbunan, Hôpital Saint-Louis, Paris; Y. Brossard, Hôpital Saint Vincent de Paul, Paris; P. Rubinstein, New York Cord Blood Bank, New York; P. Wernet, Bone Marrow Donor Center, Dusseldorf, Germany; G. Sirchia, Milan Cord Blood Bank, Milan, Italy; and C. Raffoux, France Greffe de Moelle, Hôpital Saint-Louis, Paris (who reviewed HLA typing).
- References
References
1
Gluckman E ,Broxmeyer HE ,Auerbach AD , et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-1178
Full Text | Web of Science | Medline2
Wagner JE ,Kernan NA ,Steinbuch M ,Broxmeyer HE ,Gluckman E . Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-219
CrossRef | Web of Science | Medline3
Kurtzberg J ,Laughlin M ,Graham ML , et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166
Full Text | Web of Science | Medline4
Wagner JE ,Rosenthal J ,Sweetman R , et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802
Web of Science | Medline5
Silberstein LE ,Jefferies LC . Placental-blood banking -- a new frontier in transfusion medicine. N Engl J Med 1996;335:199-201
Full Text | Web of Science | Medline6
Rubinstein P ,Rosenfield RE ,Adamson JW ,Stevens CE . Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-1690
Web of Science | Medline7
Rubinstein P ,Dobrila L ,Rosenfield RE , et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-10122
CrossRef | Web of Science | Medline8
Broxmeyer HE ,Douglas GW ,Hangoc G , et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989;86:3828-3832
CrossRef | Web of Science | Medline9
Broxmeyer HE ,Hangoc G ,Cooper S , et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A 1992;89:4109-4113
CrossRef | Web of Science | Medline10
Gluckman E. Advantages of using foetal and neonatal cells for treatment of hematological diseases in human. In: Gluckman E, Coulombel L, eds. Ontogeny of hematopoiesis aplastic anemia. Vol. 235. Paris: Colloque INSERM/John Libbey Eurotext, 1995:183-7.
11
Glucksberg H ,Storb R ,Fefer A , et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304
CrossRef | Web of Science | Medline12
Storb R ,Prentice RL ,Sullivan KM , et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by bone marrow transplantation from HLA-identical siblings. Ann Intern Med 1983;98:461-466
Web of Science | Medline13
Morrison SJ ,Wandycz AM ,Akashi K ,Globerson A ,Weissman IL . The aging of hematopoietic stem cells. Nat Med 1996;2:1011-1016
CrossRef | Web of Science | Medline14
Morrison SJ ,Prowse KR ,Ho P ,Weissman IL . Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996;5:207-216
CrossRef | Web of Science | Medline15
Mayani H ,Lansdorp PM . Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994;83:2410-2417
Web of Science | Medline16
Vaziri H ,Dragowska W ,Allsopp RC ,Thomas TE ,Harley CB ,Lansdorp PM . Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994;91:9857-9860
CrossRef | Web of Science | Medline17
Gluckman E ,O'Reilly RJ ,Wagner J ,Rubinstein P . Patents versus transplants. Nature 1996;382:108-108
CrossRef | Web of Science | Medline18
Sugarman J ,Reisner EG ,Kurtzberg J . Ethical aspects of banking placental blood for transplantation. JAMA 1995;274:1783-1785
CrossRef | Web of Science | Medline19
Marshall E . Private cord blood banks raise concern. Science 1996;271:587-587
CrossRef | Web of Science20
Brenner M . Placental blood transplant: who will benefit? Nat Med 1996;2:969-970
CrossRef | Web of Science | Medline21
de La Selle V ,Gluckman E ,Bruley-Rosset M . Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens. Blood 1996;87:3977-3983
Web of Science | Medline22
Speiser DE ,Tiercy JM ,Rufer N , et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996;87:4455-4462
Web of Science | Medline23
Petersdorf EW ,Longton GM ,Anasetti C , et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A 1996;93:15358-15363
CrossRef | Web of Science | Medline24
Petersdorf EW ,Longton GM ,Anasetti C , et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997;89:1818-1823
Web of Science | Medline
- Citing Articles (457)
Citing Articles
1
Anna Paola Iori, Veronica Valle, Alfonso Piciocchi, Giovanna Meloni, Giovanni Fernando Torelli, Antonella Vitale, Anna Maria Testi, Walter Barberi, Roberto Ricci, Filippo Milano, Barbarella Lucarelli, Maria Screnci, Maria Paola Perrone, Luca Laurenti, Fiammetta Natalino, Salvatore Perrone, Nicoletta Sacchi, William Arcese, Roberto Foà. (2012) Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia. Annals of Hematology
CrossRef2
Suhag Parikh, Paul Szabolcs. (2012) Reduced-Intensity Conditioning (RIC) in Children with Nonmalignant Disorders (NMD) Undergoing Unrelated Donor Umbilical Cord Blood Transplantation (UCBT). Biology of Blood and Marrow Transplantation 18:1, S53-S55
CrossRef3
Ong Li Ming, Fan Xiubo, Chu PatPak Yan, Gay FlorencePik Hoon, Bari Sudipto, Ang Justina May Lynn, LI Zhihong, Chen Jianzhu, Lim Sai Kiang, Bunte Ralph Milford, Hwang William Ying Khee. (2012) Co-transplantation of Ex Vivo Expanded and Unexpanded Cord Blood Units in Immunodeficient Mice using IGFBP2-Augmented Mesenchymal Cell Co-Cultures. Biology of Blood and Marrow Transplantation
CrossRef4
N. Naderi, S.M. Moazzeni, A.A. Pourfathollah, K. Alimoghaddam. (2011) High Expression of Fas Ligand on Cord Blood Dendritic Cells: A Possible Immunoregulatory Mechanism After Cord Blood Transplantation. Transplantation Proceedings 43:10, 3913-3919
CrossRef5
E. Gluckman. (2011) Milestones in umbilical cord blood transplantation. Blood Reviews 25:6, 255-259
CrossRef6
Béatrice Pédron, Valérie Guérin-El Khourouj, Jean-Hugues Dalle, Marie Ouachée-Chardin, Karima Yakouben, France Corroyez, Anne Auvrignon, Arnaud Petit, Judith Landman-Parker, Guy Leverger, André Baruchel, Ghislaine Sterkers. (2011) Contribution of HLA-A/B/C/DRB1/DQB1 Common Haplotypes to Donor Search Outcome in Unrelated Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 17:11, 1612-1618
CrossRef7
Nicolas Pineault, Lucie Boyer. (2011) Cellular-based therapies to prevent or reduce thrombocytopenia. Transfusion 51, 72S-81S
CrossRef8
Panayotis Kaloyannidis, Despina Mallouri. (2011) The role of the extracorporeal photopheresis in the management of the graft-versus-host disease. Transfusion and Apheresis Science
CrossRef9
C. E. Stevens, C. Carrier, C. Carpenter, D. Sung, A. Scaradavou. (2011) HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood 118:14, 3969-3978
CrossRef10
A. Ruggeri, R. Peffault de Latour, M. Carmagnat, E. Clave, C. Douay, J. Larghero, J.-M. Cayuela, R. Traineau, M. Robin, A. Madureira, P. Ribaud, C. Ferry, A. Devergie, D. Purtill, C. Rabian, E. Gluckman, A. Toubert, G. Socié, V. Rocha. (2011) Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases. Transplant Infectious Disease 13:5, 456-465
CrossRef11
Silvia Panseri, Alessandro Russo, Carla Cunha, Alice Bondi, Alessandro Di Martino, Silvia Patella, Elizaveta Kon. (2011) Osteochondral tissue engineering approaches for articular cartilage and subchondral bone regeneration. Knee Surgery, Sports Traumatology, Arthroscopy
CrossRef12
Peter Hollands, Karl-Heinz Preisegger. (2011) Making the Case for Private Cord Blood Banking: Mission Accomplished!. Stem Cell Reviews and Reports 7:3, 485-487
CrossRef13
Aiqing Chen, Gavin J. Clowry. (2011) Could autologous cord blood stem cell transplantation treat cerebral palsy?. Translational Neuroscience 2:3, 207-218
CrossRef14
Annalisa Ruggeri, Mary Eapen, Andromachi Scaravadou, Mitchell S. Cairo, Monica Bhatia, Joanne Kurtzberg, John R. Wingard, Anders Fasth, Luca Lo Nigro, Mouhab Ayas, Duncan Purtill, Karim Boudjedir, Wagnara Chaves, Mark C. Walters, John Wagner, Eliane Gluckman, Vanderson Rocha. (2011) Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell Disease. Biology of Blood and Marrow Transplantation 17:9, 1375-1382
CrossRef15
Kristin M. Page, Lijun Zhang, Adam Mendizabal, Stephen Wease, Shelly Carter, Tracy Gentry, Andrew E. Balber, Joanne Kurtzberg. (2011) Total Colony-Forming Units Are a Strong, Independent Predictor of Neutrophil and Platelet Engraftment after Unrelated Umbilical Cord Blood Transplantation: A Single-Center Analysis of 435 Cord Blood Transplants. Biology of Blood and Marrow Transplantation 17:9, 1362-1374
CrossRef16
Kristin M. Page, Lijun Zhang, Adam Mendizabal, Stephen Wease, Shelly Carter, Kevin Shoulars, Tracy Gentry, Andrew E. Balber, Joanne Kurtzberg. (2011) The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation. Transfusionno-no
CrossRef17
Caron A. Jacobson, Amin T. Turki, Sean M. McDonough, Kristen E. Stevenson, Haesook T. Kim, Grace Kao, Maria I. Herrera, Carol G. Reynolds, Edwin P. Alyea, Vincent T. Ho, John Koreth, Philippe Armand, Yi-Bin Chen, Karen Ballen, Robert J. Soiffer, Joseph H. Antin, Corey S. Cutler, Jerome Ritz. (2011) Immune Reconstitution after Double Umbilical Cord Blood Stem Cell Transplantation: Comparison with Unrelated Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation
CrossRef18
Eliane Gluckman, Annalisa Ruggeri, Fernanda Volt, Renato Cunha, Karim Boudjedir, Vanderson Rocha. (2011) Milestones in umbilical cord blood transplantation. British Journal of Haematology 154:4, 441-447
CrossRef19
Wolfgang Füreder, Peter Valent. (2011) Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches. Leukemia & Lymphoma 52:8, 1435-1445
CrossRef20
Tomohiro Morio, Yoshiko Atsuta, Daisuke Tomizawa, Tokiko Nagamura-Inoue, Koji Kato, Tadashi Ariga, Keisei Kawa, Kazutoshi Koike, Hisamichi Tauchi, Michiko Kajiwara, Toshiro Hara, Shunichi Kato, . (2011) Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan. British Journal of Haematology 154:3, 363-372
CrossRef21
Hye Ryun Lee, Jeong Su Park, Sue Shin, Eun Youn Roh, Jong Hyun Yoon, Kyou Sup Han, Byung Jae Kim, Robert W. Storms, Nelson J. Chao. (2011) Increased numbers of total nucleated and CD34+ cells in blood group O cord blood: an analysis of neonatal innate factors in the Korean population. Transfusionno-no
CrossRef22
T. Chandra, S. Afreen, A. Kumar, U. Singh. (2011) Correlation of Birth Weight of Full Term Infants with Cord Blood derived CD34+ Cells Concentration. Journal of Tropical Pediatrics
CrossRef23
Giovanni Fernando Torelli, Roberta Maggio, Nadia Peragine, Sabina Chiaretti, Maria Stefania Propris, Barbarella Lucarelli, Maria Screnci, Maria Grazia Mascolo, Filippo Milano, Anna Paola Iori, Gabriella Girelli, Anna Guarini, Robin Foà. (2011) Functional analysis and gene expression profile of umbilical cord blood regulatory T cells. Annals of Hematology
CrossRef24
Prakash Satwani, Carmella van de Ven, Janet Ayello, Dustin Cairo, Lynn L. Simpson, Laxmi Baxi, Mitchell S. Cairo. (2011) Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function. Cytotherapy 13:6, 730-738
CrossRef25
Marta González-Vicent, Blanca Molina, Maitane Andión, Julián Sevilla, Manuel Ramirez, Antonio Pérez, Miguel A. Díaz. (2011) Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study. European Journal of Haematology 87:1, 46-53
CrossRef26
Junya Kanda, David A. Rizzieri, Cristina Gasparetto, Gwynn D. Long, John P. Chute, Keith M. Sullivan, Ashley Morris, Clayton A. Smith, Donna E. Hogge, Janet Nitta, Kevin Song, Donna Niedzwiecki, Nelson J. Chao, Mitchell E. Horwitz. (2011) Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350 cGy) and Fludarabine Conditioning. Biology of Blood and Marrow Transplantation 17:6, 867-874
CrossRef27
Anfisa Stanevsky, Avichai Shimoni, Ronit Yerushalmi, Arnon Nagler. (2011) Cord Blood Stem Cells for Hematopoietic Transplantation. Stem Cell Reviews and Reports 7:2, 425-433
CrossRef28
Thomas Walenda, Gudrun Bokermann, Mónica S. Ventura Ferreira, Daniela M. Piroth, Thomas Hieronymus, Sabine Neuss, Martin Zenke, Anthony D. Ho, Albrecht M. Müller, Wolfgang Wagner. (2011) Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Experimental Hematology 39:6, 617-628
CrossRef29
A Alsultan, R H Giller, D Gao, J Bathurst, E Hild, L Gore, N K Foreman, A Keating, R R Quinones. (2011) GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome. Bone Marrow Transplantation 46:5, 668-675
CrossRef30
Rebecca H. Buckley. (2011) Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunologic Research 49:1-3, 25-43
CrossRef31
M. Michallet. (2011) Allogreffes de cellules souches hématopoïétiques. Transfusion Clinique et Biologique 18:2, 235-245
CrossRef32
Y. YUAN, K.-T. TSE, F. W.-Y. SIN, B. XUE, H.-H. FAN, Y. XIE, Y. XIE. (2011) Ex vivo amplification of human hematopoietic stem and progenitor cells in an alginate three-dimensional culture system. International Journal of Laboratory Hematologyno-no
CrossRef33
J. Kurtzberg. (2011) What's up with 2 cord transplantation?. Blood 117:12, 3248-3249
CrossRef34
M. Teresa de la Morena, Richard A. Gatti. (2011) A History of Bone Marrow Transplantation. Hematology/Oncology Clinics of North America 25:1, 1-15
CrossRef35
M E Bernardo, L M Ball, A M Cometa, H Roelofs, M Zecca, M A Avanzini, A Bertaina, L Vinti, A Lankester, R Maccario, O Ringden, K Le Blanc, R M Egeler, W E Fibbe, F Locatelli. (2011) Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplantation 46:2, 200-207
CrossRef36
Cécile Rénard, Vincent Barlogis, Valérie Mialou, Claire Galambrun, Delphine Bernoux, Marie Pierre Goutagny, Laurence Glasman, Anderson Dieudonné Loundou, Françoise Poitevin-Later, Françoise Dignat-George, Valérie Dubois, Christophe Picard, Christian Chabannon, Yves Bertrand, Gérard Michel. (2011) Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. British Journal of Haematology 152:3, 322-330
CrossRef37
A Iguchi, N Kawamura, R Kobayashi, S-I Takezaki, Y Ohkura, J Inamoto, J Ohshima, M Ichikawa, T Sato, M Kaneda, Y Cho, M Yamada, I Kobayashi, T Ariga. (2011) Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. Bone Marrow Transplantation
CrossRef38
Anna D. Petropoulou, Vanderson Rocha. (2011) Risk Factors and Options to Improve Engraftment in Unrelated Cord Blood Transplantation. Stem Cells International 2011, 1-8
CrossRef39
John Barrett, Eliane Gluckman, Rupert Handgretinger, Alejandro Madrigal. (2011) Point-Counterpoint: Haploidentical Family Donors versus Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 17:1, S89-S93
CrossRef40
D. H. McKenna, C. G. Brunstein. (2011) Umbilical cord blood: current status and future directions. Vox Sanguinis 100:1, 150-162
CrossRef41
Hiroto Narimatsu. (2011) Immune Reactions following Cord Blood Transplantations in Adults. Stem Cells International 2011, 1-6
CrossRef42
Ruth M. Risueño, Eleftherios Sachlos, Jong-Hee Lee, Jung Bok Lee, Seok-Ho Hong, Eva Szabo, Mickie Bhatia. (2011) Inability of Human iPSC-Hematopoietic Derivatives to Downregulate miRNAS in vivo Reveals a Block in Xenograft Hematopoietic Regeneration. STEM CELLSN/A-N/A
CrossRef43
S. Avery, W. Shi, M. Lubin, A. M. Gonzales, G. Heller, H. Castro-Malaspina, S. Giralt, N. A. Kernan, A. Scaradavou, J. N. Barker. (2010) Influence of infused cell dose and HLA-match on engraftment after double-unit cord blood allografts. Blood
CrossRef44
Angelo D’Alessandro, Giuliano Grazzini, Bruno Giardina, Lello Zolla. (2010) In Silico Analyses of Proteomic Data Suggest a Role for Heat Shock Proteins in Umbilical Cord Blood Hematopoietic Stem Cells. Stem Cell Reviews and Reports 6:4, 532-547
CrossRef45
Bindu Kanathezhath, Mark C. Walters. (2010) Umbilical Cord Blood Transplantation for Thalassemia Major. Hematology/Oncology Clinics of North America 24:6, 1165-1177
CrossRef46
C. G. Brunstein, J. A. Gutman, D. J. Weisdorf, A. E. Woolfrey, T. E. DeFor, T. A. Gooley, M. R. Verneris, F. R. Appelbaum, J. E. Wagner, C. Delaney. (2010) Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 116:22, 4693-4699
CrossRef47
Suzanne Watt. 2010. Business Models for Cord Blood. , 117-130.
CrossRef48
Kentaro Uchida, Ken Urabe, Kouji Naruse, Moritoshi Itoman. (2010) Umbilical Cord Blood-Derived Mesenchymal Cell Fate After Mouse Umbilical Cord Blood Transplantation. Transplantation 90:9, 1037-1039
CrossRef49
N Venepalli, K Rezvani, S Mielke, B N Savani. (2010) Role of allo-SCT for CML in 2010. Bone Marrow Transplantation 45:11, 1579-1586
CrossRef50
Juliet N. Barker, Courtney E. Byam, Nancy A. Kernan, Sinda S. Lee, Rebecca M. Hawke, Kathleen A. Doshi, Deborah S. Wells, Glenn Heller, Esperanza B. Papadopoulos, Andromachi Scaradavou, James W. Young, Marcel R.M. van den Brink. (2010) Availability of Cord Blood Extends Allogeneic Hematopoietic Stem Cell Transplant Access to Racial and Ethnic Minorities. Biology of Blood and Marrow Transplantation 16:11, 1541-1548
CrossRef51
Jun Hayakawa, Elizabeth G. Joyal, Jean F. Gildner, Kareem N. Washington, Oswald A. Phang, Naoya Uchida, Matthew M. Hsieh, John F. Tisdale. (2010) 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO. Transfusion 50:10, 2158-2166
CrossRef52
A.-L. Herr, N. Kabbara, C. M. S. Bonfim, P. Teira, F. Locatelli, K. Tiedemann, A. Lankester, J.-P. Jouet, C. Messina, Y. Bertrand, C. Diaz de Heredia, C. Peters, W. Chaves, S. K. Nabhan, I. Ionescu, E. Gluckman, V. Rocha. (2010) Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT. Blood 116:11, 1849-1856
CrossRef53
Roberto Francese, Paolo Fiorina. (2010) Immunological and regenerative properties of cord blood stem cells. Clinical Immunology 136:3, 309-322
CrossRef54
M Ayas, A Al-Seraihi, A Al-Jefri, A Al-Ahmari, M Al-Mahr, A Al-Ghonaium, S Al-Muhsen, H Al-Mousa, H Al-Dhekri, B Alsaud, A Eldali, A Mohamad, H Al-Humaidan, A Chadrawi, M Al-Kaff, Z Al-Hassnan, H El-Solh. (2010) Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia. Bone Marrow Transplantation 45:8, 1281-1286
CrossRef55
Michael R. Doran, Brandon D. Markway, Angelique Clark, Stavrosia Athanasas-Platsis, Gary Brooke, Kerry Atkinson, Lars K. Nielsen, Justin J. Cooper-White. (2010) Membrane Bioreactors Enhance Microenvironmental Conditioning and Tissue Development. Tissue Engineering Part C: Methods 16:3, 407-415
CrossRef56
Alice Bertaina, Maria Ester Bernardo, Maurizio Caniglia, Luciana Vinti, Giovanna Giorgiani, Franco Locatelli. (2010) Cord blood transplantation in children with haematological malignancies. Best Practice & Research Clinical Haematology 23:2, 189-196
CrossRef57
Alexander H. Schmidt, Alexander Platz, Claudia Rutt, Gerhard Ehninger. (2010) Making the Case for Private Cord Blood Banking: Mission Failed!. Stem Cell Reviews and Reports 6:2, 234-236
CrossRef58
Colleen Delaney, Mariusz Z Ratajczak, Mary J Laughlin. (2010) Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Review of Hematology 3:3, 273-283
CrossRef59
Vivien Beziat, Stéphanie Nguyen, Mark Exley, Abla Achour, Tabassonne Simon, Patrice Chevallier, Anne Sirvent, Stéphane Vigouroux, Patrice Debré, Bernard Rio, Vincent Vieillard. (2010) Shaping of iNKT cell repertoire after unrelated cord blood transplantation. Clinical Immunology 135:3, 364-373
CrossRef60
Mohamad Mohty, Beatrice Gaugler. (2010) Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation. Best Practice & Research Clinical Haematology 23:2, 275-282
CrossRef61
Meghan Delaney, Karen K. Ballen. (2010) The role of HLA in umbilical cord blood transplantation. Best Practice & Research Clinical Haematology 23:2, 179-187
CrossRef62
S.S. Tung, S. Parmar, S.N. Robinson, M. De Lima, E.J. Shpall. (2010) Ex vivo expansion of umbilical cord blood for transplantation. Best Practice & Research Clinical Haematology 23:2, 245-257
CrossRef63
H Yang, S N Robinson, J Lu, W K Decker, D Xing, D Steiner, S Parmar, N Shah, R E Champlin, M Munsell, A Leen, C Bollard, P J Simmons, E J Shpall. (2010) CD3+ and/or CD14+ depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34+ cell yields. Bone Marrow Transplantation 45:6, 1000-1007
CrossRef64
Anfisa Stanevsky, Avichai Shimoni, Ronit Yerushalmi, Arnon Nagler. (2010) Double umbilical cord blood transplant: more than a cell dose?. Leukemia & Lymphoma 51:6, 975-982
CrossRef65
Jeong Hwa Son, Yoon Jeong Heo, Mi Young Park, Hyung Hoi Kim, Kyu Sup Lee. (2010) Optimization of cryopreservation condition for hematopoietic stem cells from umbilical cord blood
. Cryobiology 60:3, 287-292
CrossRef66
Andromachi Scaradavou, Katherine M. Smith, Rebecca Hawke, Allison Schaible, Michelle Abboud, Nancy A. Kernan, James W. Young, Juliet N. Barker. (2010) Cord Blood Units with Low CD34+ Cell Viability Have a Low Probability of Engraftment after Double Unit Transplantation. Biology of Blood and Marrow Transplantation 16:4, 500-508
CrossRef67
Sari Juutistenaho, Mikko Eskola, Susanna Sainio, Kari Aranko, Riitta Kekomäki. (2010) TRANSPLANTATION AND CELLULAR ENGINEERING: Association of stress-related perinatal factors and cord blood unit hematopoietic progenitors is dependent on delivery mode. Transfusion 50:3, 663-671
CrossRef68
Maricer P Escalón, Krishna V Komanduri. (2010) Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution. Current Opinion in Oncology 22:2, 122-129
CrossRef69
Christian Leeb, Marcin Jurga, Colin McGuckin, Richard Moriggl, Lukas Kenner. (2010) Promising New Sources for Pluripotent Stem Cells. Stem Cell Reviews and Reports 6:1, 15-26
CrossRef70
D. Chatzidimitriou, E. Gavriilaki, I. Sakellari, E. Diza. (2010) Hematopoietic cell transplantation and emerging viral infections. Journal of Medical Virology 82:3, 528-538
CrossRef71
Sung W. Choi, John E. Levine, James L.M. Ferrara. (2010) Pathogenesis and Management of Graft-versus-Host Disease. Immunology and Allergy Clinics of North America 30:1, 75-101
CrossRef72
Atsuko Omori, Mami Manabe, Kaori Kudo, Kanako Tanaka, Kenji Takahashi, Ikuo Kashiwakura. (2010) Influence of obstetric factors on the yield of mononuclear cells, CD34 + cell count and volume of placental/umbilical cord blood. Journal of Obstetrics and Gynaecology Research 36:1, 52-57
CrossRef73
Ben Davies, Ngaire J. Elwood, Shan Li, Fiona Cullinane, Glenn A. Edwards, Donald F. Newgreen, Christian P. Brizard. (2010) Human Cord Blood Stem Cells Enhance Neonatal Right Ventricular Function in an Ovine Model of Right Ventricular Training. The Annals of Thoracic Surgery 89:2, 585-593.e4
CrossRef74
Evgenios Goussetis, Eftichia Petrakou, Maria Theodosaki, Vasiliki Kitra, Ioulia Peristeri, George Vessalas, Maria N. Dimopoulou, Antonia Spiropoulos, Andreas C. Papassavas, Catherine Stavropoulos-Giokas, Stelios Graphakos. (2010) Directed sibling donor cord blood banking for children with β-thalassemia major in Greece: Usage rate and outcome of transplantation for HLA-matched units. Blood Cells, Molecules, and Diseases 44:2, 107-110
CrossRef75
M. Teresa de la Morena, Richard A. Gatti. (2010) A History of Bone Marrow Transplantation. Immunology and Allergy Clinics of North America 30:1, 1-15
CrossRef76
Vanderson Rocha, Hal E. Broxmeyer. (2010) New Approaches for Improving Engraftment after Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 16:1, S126-S132
CrossRef77
Paul Szabolcs, Mitchell S. Cairo. (2010) Unrelated Umbilical Cord Blood Transplantation and Immune Reconstitution. Seminars in Hematology 47:1, 22-36
CrossRef78
K Isoyama, M Oda, K Kato, T Nagamura-Inoue, S Kai, H Kigasawa, R Kobayashi, J Mimaya, M Inoue, A Kikuchi, S Kato. (2010) Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan. Bone Marrow Transplantation 45:1, 69-77
CrossRef79
Andromachi Scaradavou. (2010) Unrelated Umbilical Cord Blood Unit Selection. Seminars in Hematology 47:1, 13-21
CrossRef80
John E. Wagner, Eliane Gluckman. (2010) Umbilical Cord Blood Transplantation: The First 20 Years. Seminars in Hematology 47:1, 3-12
CrossRef81
Margaret L. MacMillan, Mark C. Walters, Eliane Gluckman. (2010) Transplant Outcomes in Bone Marrow Failure Syndromes and Hemoglobinopathies. Seminars in Hematology 47:1, 37-45
CrossRef82
M. R. Verneris, C. G. Brunstein, J. Barker, M. L. MacMillan, T. DeFor, D. H. McKenna, M. J. Burke, B. R. Blazar, J. S. Miller, P. B. McGlave, D. J. Weisdorf, J. E. Wagner. (2009) Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 114:19, 4293-4299
CrossRef83
E Gluckman. (2009) History of cord blood transplantation. Bone Marrow Transplantation 44:10, 621-626
CrossRef84
Y. Morishima. (2009) Unrelated haematopoietic stem cell transplantation and bank. ISBT Science Series 4:n2, 318-322
CrossRef85
J Ooi. (2009) Cord blood transplantation in adults. Bone Marrow Transplantation 44:10, 661-666
CrossRef86
S S Kelly, C B S Sola, M de Lima, E Shpall. (2009) Ex vivo expansion of cord blood. Bone Marrow Transplantation 44:10, 673-681
CrossRef87
Mizue Nakajima, Takahiro Ueda, Makoto Migita, Yuki Oue, Yoshio Shima, Takashi Shimada, Yoshitaka Fukunaga. (2009) Hematopoietic capacity of preterm cord blood hematopoietic stem/progenitor cells. Biochemical and Biophysical Research Communications 389:2, 290-294
CrossRef88
K. Bradstock, M. Hertzberg, I. Kerridge, J. Svennilson, B. George, M. McGurgan, G. Huang, V. Antonenas, D. Gottlieb. (2009) Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes. Internal Medicine Journal 39:11, 744-751
CrossRef89
N. Worel, W. R. Mayr. (2009) Stem cell harvesting and transplantation. ISBT Science Series 4:n2, 193-199
CrossRef90
V Rocha, N Kabbara, I Ionescu, A Ruggeri, D Purtill, E Gluckman. (2009) Pediatric related and unrelated cord blood transplantation for malignant diseases. Bone Marrow Transplantation 44:10, 653-659
CrossRef91
C G Brunstein, D J Weisdorf. (2009) Future of cord blood for oncology uses. Bone Marrow Transplantation 44:10, 699-707
CrossRef92
Franco Locatelli. (2009) Improving cord blood transplantation in children. British Journal of Haematology 147:2, 217-226
CrossRef93
David T. Harris. (2009) Non-haematological uses of cord blood stem cells. British Journal of Haematology 147:2, 177-184
CrossRef94
Anjali J. Kaimal, Catherine C. Smith, Russell K. Laros, Aaron B. Caughey, Yvonne W. Cheng. (2009) Cost-effectiveness of Private Umbilical Cord Blood Banking. Obstetrics & Gynecology 114:4, 848-855
CrossRef95
Vanderson Rocha, Eliane Gluckman, . (2009) Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. British Journal of Haematology 147:2, 262-274
CrossRef96
Angela R. Smith, John E. Wagner. (2009) Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. British Journal of Haematology 147:2, 246-261
CrossRef97
Eliane Gluckman. (2009) Ten years of cord blood transplantation: from bench to bedside. British Journal of Haematology 147:2, 192-199
CrossRef98
Cristina Navarrete, Marcela Contreras. (2009) Cord blood banking: a historical perspective. British Journal of Haematology 147:2, 236-245
CrossRef99
Judith C. W. Marsh, Sarah E. Ball, Jamie Cavenagh, Phil Darbyshire, Inderjeet Dokal, Edward C. Gordon-Smith, Jane Keidan, Andrew Laurie, Anna Martin, Jane Mercieca, Sally B. Killick, Rhona Stewart, John A. L. Yin, . (2009) Guidelines for the diagnosis and management of aplastic anaemia. British Journal of Haematology 147:1, 43-70
CrossRef100
Peter Hollands, Catherina McCauley. (2009) Private Cord Blood Banking: Current Use and Clinical Future. Stem Cell Reviews and Reports 5:3, 195-203
CrossRef101
Xu Shi-xia, Tang Xian-hua, Xu Hai-qin, Feng Bo, Chen Hai-qing, Tang Xiang-Feng. (2009) Meta-analysis of HLA matching and the outcome of unrelated umbilical cord blood transplantation (CBT). Transplant Immunology 21:4, 234-239
CrossRef102
Suhag H. Parikh, Adam Mendizabal, Paul L. Martin, Vinod K. Prasad, Paul Szabolcs, Timothy A. Driscoll, Joanne Kurtzberg. (2009) Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Myelodysplastic Syndrome: A Single-Center Experience. Biology of Blood and Marrow Transplantation 15:8, 948-955
CrossRef103
David Steiner, Juri Gelovani, Barbara Savoldo, Simon N. Robinson, William K. Decker, Nathalie Brouard, Amer Najjar, Dongxia Xing, Hong Yang, Sufang Li, Frank Marini, Patrick A. Zweidler-McKay, Catherine M. Bollard, Elizabeth J. Shpall, Gianpietro Dotti, Paul J. Simmons. (2009) Noninvasive Bioluminescent Imaging Demonstrates Long-Term Multilineage Engraftment of Ex Vivo-Expanded CD34-Selected Umbilical Cord Blood Cells. Stem Cells 27:8, 1932-1940
CrossRef104
Bahman Delalat, Ali Akbar Pourfathollah, Masoud Soleimani, Hossein Mozdarani, Soraya Rasi Ghaemi, Ali Akbar Movassaghpour, Saeed Kaviani. (2009) Isolation and <I>ex vivo</I> expansion of human umbilical cord blood-derived CD34<SUP>+</SUP> stem cells and their cotransplantation with or without mesenchymal stem cells. Hematology 14:3, 125-132
CrossRef105
S Meyer-Monard, J Passweg, C Troeger, H-P Eberhard, E Roosnek, G Nicoloso de Faveri, Y Chalandon, A Rovo, V Kindler, O Irion, W Holzgreve, A Gratwohl, C Müller, A Tichelli, J-M Tiercy. (2009) Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells. Bone Marrow Transplantation 43:10, 771-778
CrossRef106
Kazuhiro Mochizuki, Atsushi Kikuta, Masaki Ito, Mitsuko Akaihata, Hideki Sano, Hitoshi Ohto, Mitsuaki Hosoya. (2009) Successful unrelated cord blood transplantation for chronic granulomatous disease: A case report and review of the literature. Pediatric Transplantation 13:3, 384-389
CrossRef107
Phuong L Doan, Nelson J Chao. (2009) Umbilical cord blood: biology and transplantation. Expert Review of Hematology 2:2, 197-208
CrossRef108
Ana I. Flores, David H. McKenna, M. Angeles Montalbán, Javier De la Cruz, John E. Wagner, Rafael Bornstein. (2009) Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion 49:4, 636-647
CrossRef109
Makoto Yazaki, Yoshiko Atsuta, Koji Kato, Shunichi Kato, Shuichi Taniguchi, Satoshi Takahashi, Hiroyasu Ogawa, Yasuji Kouzai, Takeshi Kobayashi, Masami Inoue, Ryoji Kobayashi, Tokiko Nagamura-Inoue, Hiroshi Azuma, Minoko Takanashi, Shunro Kai, Masao Nakabayashi, Hidehiko Saito. (2009) Incidence and Risk Factors of Early Bacterial Infections after Unrelated Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 15:4, 439-446
CrossRef110
M. L. MacMillan, D. J. Weisdorf, C. G. Brunstein, Q. Cao, T. E. DeFor, M. R. Verneris, B. R. Blazar, J. E. Wagner. (2009) Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 113:11, 2410-2415
CrossRef111
Serena Barachini, Luisa Trombi, Serena Danti, Delfo D’Alessandro, Barbara Battolla, Annalisa Legitimo, Claudia Nesti, Ilaria Mucci, Mario D′Acunto, Maria G. Cascone, Luigi Lazzeri, Letizia Mattii, Rita Consolini, Mario Petrini. (2009) Morpho-Functional Characterization of Human Mesenchymal Stem Cells from Umbilical Cord Blood for Potential Uses in Regenerative Medicine. Stem Cells and Development 18:2, 293-306
CrossRef112
Y. Atsuta, R. Suzuki, T. Nagamura-Inoue, S. Taniguchi, S. Takahashi, S. Kai, H. Sakamaki, Y. Kouzai, M. Kasai, T. Fukuda, H. Azuma, M. Takanashi, S. Okamoto, M. Tsuchida, K. Kawa, Y. Morishima, Y. Kodera, S. Kato, . (2009) Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 113:8, 1631-1638
CrossRef113
Joanne Kurtzberg. (2009) Update on umbilical cord blood transplantation. Current Opinion in Pediatrics 21:1, 22-29
CrossRef114
T E Petterson, M Gabriel, K Tiedemann, L Teague, P J Shaw, D Baker, R Bolton-Jones, H Tapp, C Oswald, M R Vowels, T A O'Brien. (2009) Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group. Bone Marrow Transplantation 43:3, 207-215
CrossRef115
Meng Wang, Yuan Yang, Dongming Yang, Fei Luo, Wenjie Liang, Shuquan Guo, Jianzhong Xu. (2009) The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126:2, 220-232
CrossRef116
Juliet N. Barker, Vanderson Rocha, Andromachi Scaradavou. (2009) Optimizing Unrelated Donor Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 15:1, 154-161
CrossRef117
Miharu Yabe, Masahiro Sako, Hiromasa Yabe, Yuko Osugi, Hidemitsu Kurosawa, Taemi Nara, Mika Tokuyama, Souichi Adachi, Chie Kobayashi, Masakatsu Yanagimachi, Yoshitoshi Ohtsuka, Yozo Nakazawa, Chitose Ogawa, Atsushi Manabe, Seiji Kojima, Tatsutoshi Nakahata, . (2008) A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia. Pediatric Transplantation 12:8, 862-867
CrossRef118
David T. Harris. (2008) Cord Blood Stem Cells: A Review of Potential Neurological Applications. Stem Cell Reviews 4:4, 269-274
CrossRef119
Priya Kumar, Todd E. Defor, Claudio Brunstein, Juliet N. Barker, John E. Wagner, Daniel J. Weisdorf, Linda J. Burns. (2008) Allogeneic Hematopoietic Stem Cell Transplantation in Adult Acute Lymphocytic Leukemia: Impact of Donor Source on Survival. Biology of Blood and Marrow Transplantation 14:12, 1394-1400
CrossRef120
Craig Sauter, Juliet N Barker. (2008) Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies. Current Opinion in Hematology 15:6, 568-575
CrossRef121
Effie W Petersdorf. (2008) Optimal HLA matching in hematopoietic cell transplantation. Current Opinion in Immunology 20:5, 588-593
CrossRef122
David T. Harris. (2008) Cord blood stem cells: worth the investment. Nature Reviews Cancer 8:10, 823-823
CrossRef123
L. F. PAVON, L. F. GAMARRA, L. C. MARTI, E. AMARO JUNIOR, C. A. MOREIRA-FILHO, M. I. CAMARGO-MATHIAS, O. K. OKAMOTO. (2008) Ultrastructural characterization of CD133 + stem cells bound to superparamagnetic nanoparticles: possible biotechnological applications. Journal of Microscopy 231:3, 374-383
CrossRef124
Ayami Yoshimi, Seiji Kojima, Shuichi Taniguchi, Junichi Hara, Toshimitsu Matsui, Yoshiyuki Takahashi, Hiroshi Azuma, Koji Kato, Tokiko Nagamura-Inoue, Shunro Kai, Shunichi Kato. (2008) Unrelated Cord Blood Transplantation for Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation 14:9, 1057-1063
CrossRef125
Masaya Okada, Yoshihiro Fujimori, Mahito Misawa, Shunro Kai, Toshiyuki Nakajima, Yoshiko Okikawa, Atsushi Satake, Hisayuki Itoi, Hiroyuki Takatsuka, Takeyoshi Itsukuma, Keisuke Nishioka, Hiroya Tamaki, Kazuhiro Ikegame, Hiroshi Hara, Hiroyasu Ogawa. (2008) Unrelated Umbilical Cord Blood Transplantation Using a TBI/FLAG Conditioning Regimen for Adults with Hematologic Malignancies. Biology of Blood and Marrow Transplantation 14:8, 896-903
CrossRef126
William Tse, Kevin D Bunting, Mary J Laughlin. (2008) New insights into cord blood stem cell transplantation. Current Opinion in Hematology 15:4, 279-284
CrossRef127
Julia A. Brown, Vassiliki A. Boussiotis. (2008) Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution. Clinical Immunology 127:3, 286-297
CrossRef128
Mikko Eskola, Sari Rekunen, Pekka Aroviita, Sari Möttönen, Vilho Hiilesmaa, Susanna Sainio, Riitta Kekomäki. (2008) Association of cord blood platelet characteristics and hematopoietic progenitor cells. Transfusion 48:5, 884-892
CrossRef129
Björn Schöttker, Tobias Feuchtinger, Michael Schumm, Erdwine Klinker, Rupert Handgretinger, Hermann Einsele, Gernot Stuhler. (2008) Five donors–one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors. Nature Clinical Practice Oncology 5:5, 291-295
CrossRef130
M de Lima, J McMannis, A Gee, K Komanduri, D Couriel, B S Andersson, C Hosing, I Khouri, R Jones, R Champlin, S Karandish, T Sadeghi, T Peled, F Grynspan, Y Daniely, A Nagler, E J Shpall. (2008) Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplantation 41:9, 771-778
CrossRef131
K Sugimoto, H Narimatsu, T Kawase, H Iida, M Watanabe, A Kohno, Y Kuwatsuka, T Uchida, M Hamaguchi, S Terakura, T Naoe, K Matsuo, M Murata, M Sawa, K Miyamura, Y Morishita. (2008) Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults. Bone Marrow Transplantation 41:8, 729-736
CrossRef132
José Mário Morgado, Rui Pratas, Paula Laranjeira, Ana Henriques, Inês Crespo, Fernando Regateiro, Artur Paiva. (2008) The phenotypical and functional characteristics of cord blood monocytes and CD14−/low/CD16+ dendritic cells can be relevant to the development of cellular immune responses after transplantation. Transplant Immunology 19:1, 55-63
CrossRef133
A. C. PAPASSAVAS, V. GIOKA, T. CHATZISTAMATIOU, T. KOKKINOS, I. ANAGNOSTAKIS, G. GECKA, I. REDOUKAS, G. PATERAKIS, C. STAVROPOULOS-GIOKAS. (2008) A strategy of splitting individual high volume cord blood units into two half subunits prior to processing increases the recovery of cells and facilitates ex vivo expansion of the infused haematopoietic progenitor cells in adults. International Journal of Laboratory Hematology 30:2, 124-132
CrossRef134
C Díaz de Heredia, J J Ortega, M A Díaz, T Olivé, I Badell, M González-Vicent, J Sánchez de Toledo. (2008) Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplantation 41:7, 627-633
CrossRef135
W W Tse, S L Zang, K D Bunting, M J Laughlin. (2008) Umbilical cord blood transplantation in adult myeloid leukemia. Bone Marrow Transplantation 41:5, 465-472
CrossRef136
Fernando O. Pinto, Irene Roberts. (2008) Cord blood stem cell transplantation for haemoglobinopathies. British Journal of Haematology 0:0, 080226145103436-???
CrossRef137
Gianfranco Mattia, Luisa Milazzo, Francesca Vulcano, Massimiliano Pascuccio, Giampiero Macioce, Hamisa Jane Hassan, Adele Giampaolo. (2008) Long–term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin–amplified in clinical grade serum–free culture. Experimental Hematology 36:2, 244-252
CrossRef138
Takashi Maeda, Eisuke Shiozawa, Homma Mayumi, Takako Usui, Hidetoshi Nakashima, Norimichi Hattori, Daisuke Adachi, Bungo Saito, Kouji Yanagisawa, Isao Matsuda, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Toshiko Yamochi-Onizuka, Masafumi Takimoto, Hidekazu Ota. (2008) Histopathology of bone marrow reconstitution after umbilical cord blood transplantation for hematological diseases. Pathology International 58:2, 126-132
CrossRef139
Jonas Mattsson, Olle Ringdén, Rainer Storb. (2008) Graft Failure after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 14:1, 165-170
CrossRef140
Masahiro Hirayama, Eiichi Azuma, Qi Jiang, Michihiro Kobayashi, Shotaro Iwamoto, Tadashi Kumamoto, Rodrick Kisenge, Hatsumi Yamamoto, Yoshihiro Komada. (2008) The reconstitution of CD45RBhiCD4+ naive T cells is inversely correlated with donor age in murine allogeneic haematopoietic stem cell transplantation. British Journal of Haematology 111:2, 700
CrossRef141
Stephanie J. Lee, Naynesh Kamani, Dennis L. Confer. (2008) Principles and Tools for Selection of Umbilical Cord Blood and Unrelated Adult Donor Grafts. Biology of Blood and Marrow Transplantation 14:1, 112-119
CrossRef142
Mitchell S. Cairo, Vanderson Rocha, Eliane Gluckman, Gregory Hale, John Wagner. (2008) Alternative Allogeneic Donor Sources for Transplantation for Childhood Diseases: Unrelated Cord Blood and Haploidentical Family Donors. Biology of Blood and Marrow Transplantation 14:1, 44-53
CrossRef143
I. Varis, V. Deneys, A.M. Mazzon, M. De Bruyere, G. Cornu, B. Brichard. (2008) Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytes. European Journal of Haematology 66:2, 107
CrossRef144
Michela Tarnani, Luca Laurenti, Patrizia Chiusolo, Federica Sorà, Idanna Innocenti, Giuseppe Leone, Simona Sica. (2008) Simultaneous double mismatched cord blood transplantation in a young patient with secondary myelodysplastic syndrome: Feasibility and complications. Leukemia & Lymphoma 49:4, 821-823
CrossRef145
Naynesh Kamani, Stephen Spellman, Carolyn Katovich Hurley, Juliet N. Barker, Franklin O. Smith, Machteld Oudshoorn, Robert Bray, Anajane Smith, Thomas M. Williams, Brent Logan, Mary Eapen, Claudio Anasetti, Michelle Setterholm, Dennis L. Confer. (2008) State of the Art Review: HLA Matching and Outcome of Unrelated Donor Umbilical Cord Blood Transplants. Biology of Blood and Marrow Transplantation 14:1, 1-6
CrossRef146
Nathan S. Fox, Frank A. Chervenak, Laurence B. McCullough. (2008) Ethical Considerations in Umbilical Cord Blood Banking. Obstetrics & Gynecology 111:1, 178-182
CrossRef147
Philippe Guardiola, Mathieu Kuentz, Frédéric Garban, Didier Blaise, Josy Reiffers, Michel Attal, Agnès Buzyn, Bruno Lioure, Pierre Bordigoni, Nathalie Fegueux, Marie-Laure Tanguy, Jean-Paul Vernant, Eliane Gluckman, Gérard Socié. (2008) Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. British Journal of Haematology 111:1, 292
CrossRef148
V Rocha, F Locatelli. (2008) Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplantation 41:2, 207-214
CrossRef149
G Bahadur, M Iqbal, S Malik, A Sanyal, R Wafa, R Noble. (2008) Admixed human embryos and stem cells: legislative, ethical and scientific advances. Reproductive BioMedicine Online 17, 25-32
CrossRef150
Carmella van de Ven, Daniel Collins, M. Brigid Bradley, Erin Morris, Mitchell S. Cairo. (2007) The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Experimental Hematology 35:12, 1753-1765
CrossRef151
Ian McNiece. (2007) Delivering cellular therapies: Lessons learned from ex vivo culture and clinical applications of hematopoietic cells. Seminars in Cell & Developmental Biology 18:6, 839-845
CrossRef152
C. -A. Rodrigues, V. Rocha, E. Gluckman. (2007) Le point sur la greffe de sang de cordon. Oncologie 9:12, 848-855
CrossRef153
Carolyn Troeger, Irene Hösli, Wolfgang Holzgreve. (2007) Cord blood for allogeneic and autologous banking. European Clinics in Obstetrics and Gynaecology 3:2, 81-87
CrossRef154
Satoshi Takahashi. (2007) Leukemia: cord blood for allogeneic stem cell transplantation. Current Opinion in Oncology 19:6, 667-672
CrossRef155
Andromachi Scaradavou, Dorothy Sung, Pablo Rubinstein. (2007) Combined neonatal blood transplants in a parent-to-F1 mouse model: Improved survival rates and stable long-term engraftment. American Journal of Hematology 82:11, 961-969
CrossRef156
Baris Kuskonmaz, Safak Gocer, Sibel Ersoy-Ewans, Fatma Cetin Ozman, Mualla Cetin, Duygu Uckan. (2007) Hyperacute graft-vs.-host disease after related HLA-identical umbilical cord blood transplantation. Pediatric Transplantation 11:7, 818-820
CrossRef157
Willem J. Van Heeckeren, Laura R. Fanning, Howard J. Meyerson, Pingfu Fu, Hillard M. Lazarus, Brenda W. Cooper, William W. Tse, Tamila L. Kindwall-Keller, Jennifer Jaroscak, Marcie R. Finney, Robert M. Fox, Luis Solchaga, Margaret Forster, Richard J. Creger, Mary J. Laughlin. (2007) Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. British Journal of Haematology 139:3, 464-474
CrossRef158
Amar Safdar, Gilhen H. Rodriguez, Marcos J. De Lima, Demetrios Petropoulos, Roy F. Chemaly, Laura L. Worth, Elizabeth J. Shpall, Kenneth V. I. Rolston, Issam I. Raad, Ka Wah Chan, Richard E. Champlin. (2007) Infections in 100 Cord Blood Transplantations. Medicine 86:6, 324-333
CrossRef159
C. G. Brunstein, J. N. Barker, D. J. Weisdorf, T. E. DeFor, J. S. Miller, B. R. Blazar, P. B. McGlave, J. E. Wagner. (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110:8, 3064-3070
CrossRef160
M B Bradley, P Satwani, L Baldinger, E Morris, C van de Ven, G Del Toro, J Garvin, D George, M Bhatia, E Roman, L A Baxter-Lowe, J Schwartz, E Qualter, R Hawks, K Wolownik, S Foley, O Militano, J Leclere, Y-K Cheung, M S Cairo. (2007) Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplantation 40:7, 621-631
CrossRef161
Christopher M. Walker, Jo-Anne H. van Burik, Todd E. De For, Daniel J. Weisdorf. (2007) Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources. Biology of Blood and Marrow Transplantation 13:9, 1106-1115
CrossRef162
E Tavernier, J-M Boiron, F Huguet, K Bradstock, N Vey, T Kovacsovics, A Delannoy, N Fegueux, P Fenaux, A Stamatoullas, O Tournilhac, A Buzyn, O Reman, C Charrin, C Boucheix, J Gabert, V Lhéritier, J-P Vernant, H Dombret, X Thomas. (2007) Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia 21:9, 1907-1914
CrossRef163
Shigesaburo Miyakoshi, Masahiro Kami, Tetsuya Tanimoto, Takuhiro Yamaguchi, Hiroto Narimatsu, Eiji Kusumi, Tomoko Matsumura, Shinsuke Takagi, Daisuke Kato, Yukiko Kishi, Naoko Murashige, Koichiro Yuji, Naoyuki Uchida, Kazuhiro Masuoka, Atsushi Wake, Shuichi Taniguchi. (2007) Tacrolimus as Prophylaxis for Acute Graft-Versus-Host Disease in Reduced Intensity Cord Blood Transplantation for Adult Patients With Advanced Hematologic Diseases. Transplantation 84:3, 316-322
CrossRef164
Nathan S. Fox, Cladd Stevens, Rodica Ciubotariu, Pablo Rubinstein, Laurence B. McCullough, Frank A. Chervenak. (2007) Umbilical cord blood collection: do patients really understand?. Journal of Perinatal Medicine 35:4, 314-321
CrossRef165
Atsuhiko Oikawa, Koichi Ito, Hirotoshi Seguchi, Motohito Okabe, Fujio Migishima, Koji Eshima, Sadahiro Azuma, Si-Young Song, Takehisa Kaneko, Nobukata Shinohara. (2007) Development of Immunocompetent Lymphocytes In Vivo From Murine Umbilical Cord Blood Cells. Transplantation 84:1, 23-30
CrossRef166
Alison E Willing, David J Eve, Paul R Sanberg. (2007) Umbilical cord blood transfusions for prevention of progressive brain injury and induction of neural recovery: an immunological perspective. Regenerative Medicine 2:4, 457-464
CrossRef167
Seitaro Terakura, Eiichi Azuma, Makoto Murata, Tadashi Kumamoto, Masahiro Hirayama, Yoshiko Atsuta, Yoshihisa Kodera, Makoto Yazaki, Tomoki Naoe, Koji Kato. (2007) Hematopoietic Engraftment in Recipients of Unrelated Donor Umbilical Cord Blood Is Affected by the CD34+ and CD8+ Cell Doses. Biology of Blood and Marrow Transplantation 13:7, 822-830
CrossRef168
Alvaro Urbano-Ispizua. (2007) Risk assessment in haematopoietic stem cell transplantation: Stem cell source. Best Practice & Research Clinical Haematology 20:2, 265-280
CrossRef169
Mary Eapen, Pablo Rubinstein, Mei-Jie Zhang, Cladd Stevens, Joanne Kurtzberg, Andromachi Scaradavou, Fausto R Loberiza, Richard E Champlin, John P Klein, Mary M Horowitz, John E Wagner. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. The Lancet 369:9577, 1947-1954
CrossRef170
Tomoko Matsumura, Hiroto Narimatsu, Masahiro Kami, Koichiro Yuji, Eiji Kusumi, Akiko Hori, Naoko Murashige, Yuji Tanaka, Kazuhiro Masuoka, Atsushi Wake, Shigesaburo Miyakoshi, Yoshinobu Kanda, Shuichi Taniguchi. (2007) Cytomegalovirus Infections following Umbilical Cord Blood Transplantation Using Reduced Intensity Conditioning Regimens for Adult Patients. Biology of Blood and Marrow Transplantation 13:5, 577-583
CrossRef171
K H Yoo, S H Lee, H-J Kim, K W Sung, H L Jung, E J Cho, H K Park, H A Kim, H H Koo. (2007) The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplantation 39:9, 515-521
CrossRef172
Juliana Fernandes, Vanderson Rocha, Marie Robin, Régis Peffault de Latour, Richard Traineau, Agnès Devergie, Patricia Ribaud, Delphine Réa, Jérôme Larghero, Eliane Gluckman, Gérard Socié. (2007) Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. British Journal of Haematology 137:3, 248-251
CrossRef173
A. Burd, K. Ahmed, S. Lam, T. Ayyappan, L. Huang. (2007) Stem cell strategies in burns care. Burns 33:3, 282-291
CrossRef174
Gabrielle N. Samuel, Ian H. Kerridge. (2007) Equity, Utility, and the Marketplace: Emerging Ethical Issues of Umbilical Cord Blood Banking in Australia. Journal of Bioethical Inquiry 4:1, 57-63
CrossRef175
Maria Siemionow, Galip Agaoglu. (2007) Tissue Transplantation in Plastic Surgery. Clinics in Plastic Surgery 34:2, 251-269
CrossRef176
William Ying Khee Hwang, Miny Samuel, Daryl Tan, Liang Piu Koh, Winston Lim, Yeh Ching Linn. (2007) A Meta-Analysis of Unrelated Donor Umbilical Cord Blood Transplantation versus Unrelated Donor Bone Marrow Transplantation in Adult and Pediatric Patients. Biology of Blood and Marrow Transplantation 13:4, 444-453
CrossRef177
C Lemarie, B Esterni, B Calmels, B Dazey, V Lapierre, L Lecchi, A Meyer, D Rea, I Thuret, H Chambost, C Curtillet, C Chabannon, G Michel. (2007) CD34+ progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation. Bone Marrow Transplantation 39:8, 453-460
CrossRef178
Claudio G Brunstein, K Scott Baker, John E Wagner. (2007) Umbilical cord blood transplantation for myeloid malignancies. Current Opinion in Hematology 14:2, 162-169
CrossRef179
J.-A. van Burik, C. G. Brunstein. (2007) Infectious complications following unrelated cord blood transplantation. Vox Sanguinis 0:0, 070302022831001-???
CrossRef180
Shing Leng Chan, Michael Choi, Stephan Wnendt, Morey Kraus, Eileen Teng, Hwei Fen Leong, Shosh Merchav. (2007) Enhanced In Vivo Homing of Uncultured and Selectively Amplified Cord Blood CD34 + Cells by Cotransplantation with Cord Blood-Derived Unrestricted Somatic Stem Cells. Stem Cells 25:2, 529-536
CrossRef181
John Lister, Jeffrey F. Gryn, Karina L. McQueen, David T. Harris, James M. Rossetti, Richard K. Shadduck. (2007) Multiple Unit HLA-Unmatched Sex-Mismatched Umbilical Cord Blood Transplantation for Advanced Hematological Malignancy. Stem Cells and Development 16:1, 177-186
CrossRef182
H Narimatsu, S Terakura, K Matsuo, T Oba, T Uchida, H Iida, M Hamaguchi, M Watanabe, A Kohno, M Murata, M Sawa, K Miyamura, Y Morishita. (2007) Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplantation 39:1, 31-39
CrossRef183
Young-Ho Lee. (2007) Cord Blood - Current Status and Perspective. The Korean Journal of Hematology 42:3, 181
CrossRef184
Yong Jik Lee, Hyun Dong Lee, Jeong Ok Hah, Min Kyoung Kim, Kyung Hee Lee, Myung Soo Hyun. (2007) Outcome of Hematopoietic Stem Cell Transplantation: In Children and Adolescent Patients at Yeungnam University Hospital. The Korean Journal of Hematology 42:4, 317
CrossRef185
Thomas Brune, Henk S.P. Garritsen. (2007) Potential of Directed Cord Blood Donations for the Treatment of Patients with Hematologic Disorders. Transfusion Medicine and Hemotherapy 34:2, 100-103
CrossRef186
Juliet N. Barker. (2007) Who Should Get Cord Blood Transplants?. Biology of Blood and Marrow Transplantation 13, 78-82
CrossRef187
Karen K. Ballen, N. Rebecca Haley, Joanne Kurtzberg, Thomas A. Lane, Bruce R. Lindgren, John P. Miller, Bruce Newman, Jeff McCullough. (2006) Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. Transfusion 46:12, 2063-2070
CrossRef188
N Naeem, A Eyzaguirre, J A Kern, H M Lazarus, R B Hejal, M J Laughlin, E F O Kern. (2006) Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Transplantation 38:11, 733-738
CrossRef189
Jean-Michel Boiron, Bernard Dazey, Christian Cailliot, Béatrice Launay, Michel Attal, Frédéric Mazurier, Ian K. McNiece, Zoran Ivanovic, Jean Caraux, Gérald Marit, Josy Reiffers. (2006) Large-scale expansion and transplantation of CD34+ hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 46:11, 1934-1942
CrossRef190
Thomas J. George, Michele W. Sugrue, Sarah N. George, John R. Wingard. (2006) Factors associated with parameters of engraftment potential of umbilical cord blood. Transfusion 46:10, 1803-1812
CrossRef191
Claudio G. Brunstein, John E. Wagner. (2006) Cord blood transplantation for adults. Vox Sanguinis 91:3, 195-205
CrossRef192
Navneet S. Majhail, Claudio G. Brunstein, John E. Wagner. (2006) Double umbilical cord blood transplantation. Current Opinion in Immunology 18:5, 571-575
CrossRef193
William Arcese, Alessandra Picardi, Raffaella Cerretti, Laura Cudillo, Gottardo De Angelis, Luca Franceschini, Lidia De Felice, Massimiliano Postorino. (2006) The Therapeutic Use of Cord Blood. Cell Preservation Technology 4:3, 161-168
CrossRef194
Yue Zhang, Chou Chai, Xue-Song Jiang, Swee-Hin Teoh, Kam W. Leong. (2006) Co-culture of Umbilical Cord Blood CD34 + Cells with Human Mesenchymal Stem Cells. Tissue Engineering 0:0, 060913044658049
CrossRef195
Yue Zhang, Chou Chai, Xue-Song Jiang, Swee-Hin Teoh, Kam W. Leong. (2006) Co-culture of Umbilical Cord Blood CD34þ Cells with Human Mesenchymal Stem Cells. Tissue Engineering 12:8, 2161-2170
CrossRef196
Eliane Gluckman. (2006) Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 12:8, 808-812
CrossRef197
Andrea Finocchi, Maria Luisa Romiti, Silvia Di Cesare, Pamela Puliafito, Simone Pensieroso, Ippolita Rana, Rita Pinto, Caterina Cancrini, Giulio De Rossi, Maurizio Caniglia, Paolo Rossi. (2006) Rapid T-cell Receptor CD4+ Repertoire Reconstitution and Immune Recovery in Unrelated Umbilical Cord Blood Transplanted Pediatric Leukemia Patients. Journal of Pediatric Hematology/Oncology 28:7, 403-411
CrossRef198
K. F. Bradstock, M. S. Hertzberg, I. H. Kerridge, J. Svennilson, M. McGurgan, G. Huang, V. Antonenas, D. J. Gottlieb. (2006) Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre. Internal Medicine Journal 36:6, 355-361
CrossRef199
Jordan H. Perlow. (2006) Umbilical cord blood banking options and the prenatal patient. Stem Cell Reviews 2:2, 127-131
CrossRef200
M. Oudshoorn, S.M. van Walraven, J.N.A. Bakker, J.L.W.T. Lie, H.G.M. v.d. Zanden, M.B.A. Heemskerk, F.H.J. Claas. (2006) Hematopoietic Stem Cell Donor Selection: the Europdonor Experience. Human Immunology 67:6, 405-412
CrossRef201
R F Duarte, D Pamphilon, J Cornish, B E Shaw, D Samson, C Craddock, D Marks, G J Mufti, R L Powles, J F Apperley, J A Madrigal, J M Goldman. (2006) Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London – 2005. Bone Marrow Transplantation 37:10, 901-908
CrossRef202
Eric S. Sandler, Alan Homans, Lynda Mandell, Michael Amylon, Donna A. Wall, Meenakshi Devidas, George R. Buchanan, Jeffrey M. Lipton, Amy L. Billett. (2006) Hematopoietic Stem Cell Transplantation After First Marrow Relapse of Non-T, Non-B Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 28:4, 210-215
CrossRef203
Jerome Larghero, Delphine Rea, Yves Brossard, Jacqueline Van Nifterik, Veronique Delasse, Isabelle Robert, Nicole Biscay, Elisabeth Chantre, Emmanuel Raffoux, Gerard Socie, Eliane Gluckman, Marc Benbunan, Jean-Pierre Marolleau. (2006) Prospective flow cytometric evaluation of nucleated red blood cells in cord blood units and relationship with nucleated and CD34+ cell quantification. Transfusion 46:3, 403-406
CrossRef204
William Tse, Kevin D Bunting, Mary J Laughlin. (2006) Umbilical cord blood transplantation: an alternative for adult patients. Current Opinion in Organ Transplantation 11:1, 37-45
CrossRef205
Claudio G. Brunstein, John E. Wagner. (2006) Umbilical Cord Blood Transplantation and Banking. Annual Review of Medicine 57:1, 403-417
CrossRef206
S N Robinson, J Ng, T Niu, H Yang, J D McMannis, S Karandish, I Kaur, P Fu, M Del Angel, R Messinger, F Flagge, M de Lima, W Decker, D Xing, R Champlin, E J Shpall. (2006) Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplantation 37:4, 359-366
CrossRef207
Donald B Kohn, Jan A Nolta, Gay M Crooks. 2006. Hematopoietic Stem Cells. .
CrossRef208
J Stylianou, M Vowels, K Hadfield. (2006) Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB. Cytotherapy 8:1, 57-61
CrossRef209
Mahito Misawa, Shunro Kai, Masaya Okada, Toshiyuki Nakajima, Kaori Nomura, Takeshi Wakae, Akinari Toda, Hisayuki Itoi, Hiroyuki Takatsuka, Takeyoshi Itsukuma, Keisuke Nishioka, Yoshihiro Fujimori, Hiroyasu Ogawa, Hiroshi Hara. (2006) Reduced-Intensity Conditioning Followed by Unrelated Umbilical Cord Blood Transplantation for Advanced Hematologic Malignancies: Rapid Engraftment in Bone Marrow. International Journal of Hematology 83:1, 74-79
CrossRef210
Ki-Soo Park, Yong-Soon Lee, Kyung-Sun Kang. (2006) In vitro neuronal and osteogenic differentiation of mesenchymal stem cells from human umbilical cord blood. Journal of Veterinary Science 7:4, 343
CrossRef211
Vincent Laroche, David H. McKenna, Gary Moroff, Therese Schierman, Diane Kadidlo, Jeffrey McCullough. (2005) Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion 45:12, 1909-1916
CrossRef212
Kelly K. Sawczyn, Ralph Quinones, Janet Malcolm, Nicholas Foreman, Tim Garrington, Lia Gore, Dexiang Gao, Roger Giller. (2005) Cord blood transplant in childhood ALL. Pediatric Blood & Cancer 45:7, 964-970
CrossRef213
Alan P. Knutsen, Michael E. Kelly, Donna A. Wall. (2005) Umbilical Cord Blood Stem Cell Transplantation in Severe T-Cell Immunodeficiency Disorders. Pediatric Asthma, Allergy & Immunology 18:4, 189-200
CrossRef214
G Kögler, J Enczmann, V Rocha, E Gluckman, P Wernet. (2005) High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplantation 36:12, 1033-1041
CrossRef215
Chih-Chao Chang, Prakash Satwani, Nora Oberfield, George Vlad, Lynn L. Simpson, Mitchell S. Cairo. (2005) Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: A comparative study of naïve and antigenic-specific cord blood Treg cells. Experimental Hematology 33:12, 1508-1520
CrossRef216
Thomas O. Kleen, Suzanne Kadereit, Laura R. Fanning, Jennifer Jaroscak, Pingfu Fu, Howard J. Meyerson, Lara Kulchycki, Laura F. Slivka, Margaret Kozik, Magdalena Tary-Lehmann, Mary J. Laughlin. (2005) Recipient-Specific Tolerance after HLA-Mismatched Umbilical Cord Blood Stem Cell Transplantation. Transplantation 80:9, 1316-1322
CrossRef217
V. Adami, W. Malangone, E. Falasca, L. Marini, A. Risso, S. Crini, E. Toniutti, E. Passoni Ferraro, G. Del Frate, M. Pittino, F. Biffoni, C. Rinaldi, A. Degrassi. (2005) A closed system for the clinical banking of umbilical cord blood. Blood Cells, Molecules, and Diseases 35:3, 389-397
CrossRef218
OLLE RINGDÉN, KATARINA LE BLANC. (2005) Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS 113:11-12, 813-830
CrossRef219
Jordan H. Perlow. (2005) The Case Against Private Umbilical Cord Blood Banking. Obstetrics & Gynecology 106:4, 865-866
CrossRef220
Gerard J. Madlambayan, Ian Rogers, Daniel C. Kirouac, Nobuko Yamanaka, Frèdèric Mazurier, Monica Doedens, Robert F. Casper, John E. Dick, Peter W. Zandstra. (2005) Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Experimental Hematology 33:10, 1229-1239
CrossRef221
Seo H. Lee, Hyun Soo Lee, Hyung Cheol Moon, Dae Ho Kim, Young Shik Park, Baek Hwang, Hyeon Y. Lee. (2005) The Effect of α-pinene from Pinus densiflora S. and a Polysaccharide from Angelica gigas Nakai on Differentiation and Proliferation of Human Embryonic Stem Cells. Cytotechnology 49:2-3, 87-94
CrossRef222
Philip McGlave. (2005) Allogeneic transplantation for chronic myelogenous leukemia. Hematology 10:4, 15-18
CrossRef223
H Bittencourt, V Rocha, A Filion, I Ionescu, A-L Herr, F Garnier, L Ades, H Esperou, A Devergie, P Ribaud, G Socie, E Gluckman. (2005) Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders. Bone Marrow Transplantation 36:5, 431-435
CrossRef224
Elisabet Cant??, Jos?? L. Rodr??guez-S??nchez, S??lvia Vidal. (2005) Naive CD4+ Cells from Cord Blood Can Generate Competent Th Effector Cells. Transplantation 80:6, 850-858
CrossRef225
Serdar H. Ural, Mary D. Sammel, Karin J. Blakemore. (2005) Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model. American Journal of Obstetrics and Gynecology 193:3, 990-994
CrossRef226
J Motwani, S E Lawson, P J Darbyshire. (2005) Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia – experience in a single UK centre. Bone Marrow Transplantation 36:5, 405-410
CrossRef227
Alan P. Knutsen. (2005) Conventional Treatment of Primary Immunodeficiency Disorders. Pediatric Asthma, Allergy & Immunology 18:3, 140-155
CrossRef228
C. Troeger, D. V. Surbek, W. Holzgreve. (2005) Stammzellen aus Nabelschnurblut. Der Gynäkologe 38:9, 829-837
CrossRef229
L. Lecchi, S. Giovanelli, M. Polese, L. Musacchio, F. Garcea, I. Ratti, M. Brasca, P. Rebulla. (2005) Repository Facility: The Milano Cord Blood Bank. Cell Preservation Technology 3:3, 141-147
CrossRef230
Prakash Satwani, Janet Ayello, Carmella Ven, Allison F. O'Neill, Lynn L. Simpson, Laxmi Baxi, Mitchell S. Cairo. (2005) Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function*. British Journal of Haematology 130:2, 284-292
CrossRef231
Yukiko Kishi, Masahiro Kami, Shigesaburo Miyakoshi, Yoshinobu Kanda, Naoko Murashige, Takanori Teshima, Eiji Kusumi, Shigeo Hara, Tomoko Matsumura, Koichiro Yuji, Kazuhiro Masuoka, Atsushi Wake, Shinichi Morinaga, Mineo Kanemaru, Tatsuyuki Hayashi, Yuji Tanaka, Shuichi Taniguchi. (2005) Early Immune Reaction after Reduced-Intensity Cord-Blood Transplantation for Adult Patients. Transplantation 80:1, 34-40
CrossRef232
C FAN, Q ZHANG, F TANG, Z HAN, G WANG, Z HAN. (2005) Human umbilical cord blood cells express neurotrophic factors. Neuroscience Letters 380:3, 322-325
CrossRef233
Joanne Kurtzberg, Mitchell S. Cairo, John K. Fraser, LeeAnn Baxter-Lowe, Geoff Cohen, Shelly L. Carter, Nancy A. Kernan. (2005) Results of the Cord Blood Transplantation (COBLT) Study unrelated donor banking program. Transfusion 45:6, 842-855
CrossRef234
Mitchell S. Cairo, Elizabeth L. Wagner, John Fraser, Geoff Cohen, Carmella van de Ven, Shelly L. Carter, Nancy A. Kernan, Joanne Kurtzberg. (2005) Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Transfusion 45:6, 856-866
CrossRef235
Jeffrey L. Ecker, Michael F. Greene. (2005) The Case Against Private Umbilical Cord Blood Banking. Obstetrics & Gynecology 105:6, 1282-1284
CrossRef236
JEAN-HUGUES DALLE, JOS?? MENEZES, ??RIC WAGNER, MARIE BLAGDON, JOSETTE CHAMPAGNE, MARTIN A. CHAMPAGNE, MICHEL DUVAL. (2005) Characterization of Cord Blood Natural Killer Cells: Implications for Transplantation and Neonatal Infections. Pediatric Research 57:5 Part 1, 649-655
CrossRef237
Erich Vargas-Díez, Amaro García-Díez, Alicia Marín, Jesus Fernández-Herrera. (2005) Life-threatening graft-vs-host disease. Clinics in Dermatology 23:3, 285-300
CrossRef238
M. Brigid Bradley, Mitchell S. Cairo. (2005) Cord Blood Immunology and Stem Cell Transplantation. Human Immunology 66:5, 431-446
CrossRef239
Juliet N. Barker, Rachael E. Hough, Jo-Anne H. van Burik, Todd E. DeFor, Margaret L. MacMillan, Michele R. O’Brien, John E. Wagner. (2005) Serious Infections after Unrelated Donor Transplantation in 136 Children: Impact of Stem Cell Source. Biology of Blood and Marrow Transplantation 11:5, 362-370
CrossRef240
Masoud Soleimani ., Hossein Mozdarani ., AliAkbar Pourfathollah ., Yousef Mortazavi ., Kamran Alimoghaddam ., Mahin Nikogoftar ., Zahra Zonobi ., Abbas Hajifathali .. (2005) A Co-culture System for Expansion of Nonenriched Cord Blood Stem/Progenitor Cells. Biotechnology(Faisalabad) 4:4, 310-315
CrossRef241
Rafael Bornstein, Aan I. Flores, M. Angeles Montalbán, Manuel J. del Rey, Javier de la Serna, Florinda Gilsanz. (2005) A Modified Cord Blood Collection Method Achieves Sufficient Cell Levels for Transplantation in Most Adult Patients. Stem Cells 23:3, 324-334
CrossRef242
Sabeen Askari, John Miller, Gayl Chrysler, Jeffrey McCullough. (2005) Impact of donor- and collection-related variables on product quality in ex utero cord blood banking. Transfusion 45:2, 189-194
CrossRef243
Arnon Nagler. 2005. Stem Cell Transplantation. .
CrossRef244
Pilar Solves, Alfredo Perales, Rosa Moraga, Eric Saucedo, M.Angeles Soler, Javier Monleon. (2005) Maternal, Neonatal and Collection Factors Influencing the Haematopoietic Content of Cord Blood Units. Acta Haematologica 113:4, 241-246
CrossRef245
W Tse, MJ Laughlin. (2005) Cord blood transplantation in adult patients. Cytotherapy 7:3, 228-242
CrossRef246
Yong-Man Kim, Min-Hyung Jung, Ha-Young Song, Hyun Ok Yang, Sung-Tae Lee, Jong-Hyeok Kim, Young-Tak Kim, Joo-Hyun Nam, Jung-Eun Mok. (2005) Ex Vivo Expansion of Human Umbilical Cord Blood-Derived T-Lymphocytes with Homologous Cord Blood Plasma. The Tohoku Journal of Experimental Medicine 205:2, 115-122
CrossRef247
E Gluckman, V Rocha. (2005) History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy 7:3, 219-227
CrossRef248
S Robinson, T Niu, M de Lima, J Ng, H Yang, J McMannis, S Karandish, T Sadeghi, P Fu, M del Angel, S O'Connor, R Champlin, E Shpall. (2005) Ex vivo expansion of umbilical cord blood. Cytotherapy 7:3, 243-250
CrossRef249
T. Fietz, R. Arnold, G. Massenkeil, K. Rieger, B. Reufi, E. Thiel, W.U. Knauf. (2005) Altered Growth Characteristics of Cord Blood Cells after in vivo Exposure to Maternal Acute Myeloid Leukemia and Chemotherapy. Acta Haematologica 114:2, 121-124
CrossRef250
K-S Kang, SW Kim, YH Oh, JW Yu, K-Y Kim, HK Park, C-H Song, H Han. (2005) A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 7:4, 368-373
CrossRef251
Sanz, Miguel A., . (2004) Cord-Blood Transplantation in Patients with Leukemia — A Real Alternative for Adults. New England Journal of Medicine 351:22, 2328-2330
Full Text252
Laughlin, Mary J., Eapen, Mary, Rubinstein, Pablo, Wagner, John E., Zhang, Mei-Jei, Champlin, Richard E., Stevens, Cladd, Barker, Juliet N., Gale, Robert P., Lazarus, Hillard M., Marks, David I., van Rood, Jon J., Scaradavou, Andromachi, Horowitz, Mary M., . (2004) Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia. New England Journal of Medicine 351:22, 2265-2275
Full Text253
Rocha, Vanderson, Labopin, Myriam, Sanz, Guillermo, Arcese, William, Schwerdtfeger, Rainer, Bosi, Alberto, Jacobsen, Niels, Ruutu, Tapani, de Lima, Marcos, Finke, Jürgen, Frassoni, Francesco, Gluckman, Eliane, . (2004) Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia. New England Journal of Medicine 351:22, 2276-2285
Full Text254
Vanderson Rocha, Guillermo Sanz, Eliane Gluckman. (2004) Umbilical cord blood transplantation. Current Opinion in Hematology 11:6, 375-385
CrossRef255
P Aroviita, K Teramo, V Hiilesmaa, P Westman, R Kekomäki. (2004) Birthweight of full-term infants is associated with cord blood CD34+ cell concentration. Acta Paediatrica 93:10, 1323-1329
CrossRef256
Tian-Xue Fan, Hiroko Hisha, Tie-Nan Jin, Kikuya Sugiura, Muneo Inaba, Guo-Xiang Yang, Qing Li, Xiao-Li Wang, Chang-Ye Song, Yun-Ze Cui, Qiang Li, Yuming Zhang, Xiao-Guang Zhang, Hong-Xue Fan, Susumu Ikehara. (2004) Induction of Tolerance in Quadruple Chimeric Mice. Stem Cells 22:5, 683-695
CrossRef257
Enmei Liu, Helen K. W. Law, Yu-Lung Lau. (2004) Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. British Journal of Haematology 126:4, 517-526
CrossRef258
Nelson J. Chao, Liang-Piu Koh, Gwynn D. Long, Cristina Gasparetto, Mitchell Horwitz, Ashley Morris, Martha Lassiter, Keith M. Sullivan, David A. Rizzieri. (2004) Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. Biology of Blood and Marrow Transplantation 10:8, 569-575
CrossRef259
Hiromasa Yabe, Hiroyasu Inoue, Masae Matsumoto, Satoshi Hamanoue, Aiko Hiroi, Takashi Koike, Masahiro Sako, Mitsuhiro Fujiwara, Yasunori Ueda, Etsuko Maruya, Hiroh Saji, Shunichi Kato, Miharu Yabe. (2004) Unmanipulated HLA-Haploidentical Bone Marrow Transplantation for the Treatment of Fatal, Nonmalignant Diseases in Children and Adolescents. International Journal of Hematology 80:1, 78-82
CrossRef260
Giuseppina Bonanno, Alessandro Perillo, Sergio Rutella, Daniela Giovanna de Ritis, Andrea Mariotti, Maria Marone, Franco Meoni, Giovanni Scambia, Giuseppe Leone, Salvatore Mancuso, Luca Pierelli. (2004) Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion 44:7, 1087-1097
CrossRef261
Jennifer G. Hall, Paul L. Martin, Susan Wood, Joanne Kurtzberg. (2004) Unrelated Umbilical Cord Blood Transplantation for an Infant With ??-Thalassemia Major. Journal of Pediatric Hematology/Oncology 26:6, 382-385
CrossRef262
Rainer Storb. (2004) History of pediatric stem cell transplantation. Pediatric Transplantation 8, 5-11
CrossRef263
Cesare G. Perotti, Claudia Del Fante, Gianluca Viarengo, Pietro Papa, Loretta Rocchi, Paola Bergamaschi, Laura Bellotti, Andrea Marchesi, Laura Salvaneschi. (2004) A new automated cell washer device for thawed cord blood units. Transfusion 44:6, 900-906
CrossRef264
M.A. Mohyeddin Bonab, K.A. Alimoghaddam, Z.A. Goliaei, A.R. Ghavamzadeh. (2004) Which factors can affect cord blood variables?. Transfusion 44:5, 690-693
CrossRef265
Eliane Gluckman. (2004) Ex vivo expansion of cord blood cells. Experimental Hematology 32:5, 410-412
CrossRef266
John E Wagner, Catherine M Verfaillie. (2004) Ex vivo expansion of umbilical cord blood hemopoietic stem and progenitor cells. Experimental Hematology 32:5, 412-413
CrossRef267
Meghan A. Higman, Georgia B. Vogelsang. (2004) Chronic graft versus host disease. British Journal of Haematology 125:4, 435-454
CrossRef268
Mihaela Chivu, Carmen C. Diaconu, Coralia Bleotu, Irina Alexiu, Lorelei Brasoveanu, C. Cernescu. (2004) The comparison of different protocols for expansion of umbilical-cord blood hematopoietic stem cells. Journal of Cellular and Molecular Medicine 8:2, 223-231
CrossRef269
Eliane Gluckman, Vanderson Rocha, William Arcese, Gérard Michel, Guillermo Sanz, Ka-Wah Chan, Tsuneo A Takahashi, Juan Ortega, Alexandra Filipovich, Franco Locatelli, Shigetaka Asano, Franca Fagioli, Marcus Vowels, Anne Sirvent, Jean-Philippe Laporte, Karin Tiedemann, Sergio Amadori, Manuel Abecassis, Pierre Bordigoni, Blanca Diez, Peter J Shaw, Ajay Vora, Maurizio Caniglia, Federico Garnier, Irina Ionescu, Joan Garcia, Gesine Koegler, Paolo Rebulla, Sylvie Chevret, on behalf of the Eurocord Group. (2004) Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Experimental Hematology 32:4, 397-407
CrossRef270
Inge Van haute, Nele Lootens, Saskia De Smet, Carine De Buck, Linda Verdegem, Katrien Vanheusden, Jef Pinxteren, Bart Vandekerckhove. (2004) Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative?. Transfusion 44:4, 547-554
CrossRef271
Rebecca H. Buckley. (2004) M
olecular Defects in Human Severe Combined Immunodeficiency and Approaches to Immune Reconstitution . Annual Review of Immunology 22:1, 625-655
CrossRef272
Franco Locatelli, Piero De Stefano. (2004) New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies. British Journal of Haematology 125:1, 3-11
CrossRef273
Ifeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison, Ying-Kuen Cheung, Carmella Van De Ven, Gustavo del Toro, James Garvin, Diane George, M.Brigid Bradley, Karen Wolownik, Cheryl Wischhover, Joseph Levy, Donna Skerrett, Mitchell S Cairo. (2004) A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biology of Blood and Marrow Transplantation 10:4, 246-258
CrossRef274
John P. Chute, Garrett Muramoto, Jennifer Fung, Carol Oxford. (2004) Quantitative Analysis Demonstrates Expansion of SCID-Repopulating Cells and Increased Engraftment Capacity in Human Cord Blood Following Ex Vivo Culture with Human Brain Endothelial Cells. Stem Cells 22:2, 202-215
CrossRef275
Mary B Newman, Cyndy D Davis, Cesar V Borlongan, Dwaine Emerich, Paul R Sanberg. (2004) Transplantation of human umbilical cord blood cells in the repair of CNS diseases. Expert Opinion on Biological Therapy 4:2, 121-130
CrossRef276
P. Aroviita, J. Partanen, P. Sistonen, K. Teramo, R. Kekomaki. (2004) High birth weight is associated with human leukocyte antigen (HLA) DRB1*13 in full-term infants. European Journal of Immunogenetics 31:1, 21-26
CrossRef277
Nashaat S. Hamza, Michelle Lisgaris, Gopala Yadavalli, Laura Nadeau, Robert Fox, Pingfu Fu, Hillard M. Lazarus, Omer N. Koc, Robert A. Salata, Mary J. Laughlin. (2004) Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. British Journal of Haematology 124:4, 488-498
CrossRef278
Dimitrios G. Bouzianas. (2004) Cobblestone area measuring (CAM) assay: a new way of assessing the potential of human haemopoietic stem cells. Methods in Cell Science 25:3-4, 201-210
CrossRef279
FEDERICO MOSCARDÓ, GUILLERMO F SANZ, MIGUEL A SANZ. (2004) Unrelated-Donor Cord Blood Transplantation for Adult Hematological Malignancies. Leukemia & Lymphoma 45:1, 11-18
CrossRef280
Liang-Piu Koh, Nelson J Chao. (2004) Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biology of Blood and Marrow Transplantation 10:1, 1-22
CrossRef281
Randal K. Wada, Andrea Bradford, Margery Moogk, Robyn Yim, D. Michael Strong, Jonathan Drachman, Jo Anna Reems. (2004) Cord blood units collected at a remote site: a collaborative endeavor to collect umbilical cord blood through the Hawaii Cord Blood Bank and store the units at the Puget Sound Blood Center. Transfusion 44:1, 111-118
CrossRef282
Hyun Ok Kim. (2004) Use of Cord Blood Stem Cells in Cell Therapy. Journal of the Korean Medical Association 47:10, 957
CrossRef283
Robert C Atkins, Mark C Walters. (2003) Haematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opinion on Biological Therapy 3:8, 1215-1224
CrossRef284
J.C.W. Marsh, S.E. Ball, P. Darbyshire, E.C. Gordon-Smith, A.J. Keidan, A. Martin, S.R. McCann, J. Mercieca, D. Oscier, A.W.W. Roques, J.A.L. Yin, . (2003) Guidelines for the diagnosis and management of acquired aplastic anaemia. British Journal of Haematology 123:5, 782-801
CrossRef285
F Baron. (2003) Hematopoietic cell transplantation: five decades of progress. Archives of Medical Research 34:6, 528-544
CrossRef286
H. Sovalat, E. Racadot, M. Ojeda, H. Lewandowski, V. Chaboute, P. Henon. (2003) CD34+ Cells and CD34+CD38- Subset from Mobilized Blood Show Different Patterns of Adhesion Molecules Compared to Those from Steady-State Blood, Bone Marrow, and Cord Blood. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 12:5, 473-489
CrossRef287
Paul Veys, Persis Amrolia, Kanchana Rao. (2003) The role of haploidentical stem cell transplantation in the management of children with haematological disorders. British Journal of Haematology 123:2, 193-206
CrossRef288
Tokiko Nagamura-Inoue, Mika Shioya, Michiko Sugo, Yan Cui, Atsuko Takahashi, Satomi Tomita, Yizhou Zheng, Kei Takada, Hideki Kodo, Shigetaka Asano, Tsuneo A. Takahashi. (2003) Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 43:9, 1285-1295
CrossRef289
Tsuneo Itoh, Masayoshi Minegishi, Junko Fushimi, Hiroyuki Takahashi, Yoshinori Kudo, Akira Suzuki, Ayuko Narita, Yuko Sato, Kozo Akagi, Yuichi Wada, Akira Saito, Miwako Kikuchi, Kunihiro Okamura, Mitsuo Kaku, Shigeru Tsuchiya. (2003) A simple controlled-rate freezing method without a rate-controlled programmed freezer provides optimal conditions for both large-scale and small-scale cryopreservation of umbilical cord blood cells. Transfusion 43:9, 1303-1308
CrossRef290
Juliet N. Barker, John E. Wagner. (2003) Umbilical-cord blood transplantation for the treatment of cancer. Nature Reviews Cancer 3:7, 526-532
CrossRef291
Hidehisa Tanaka, Shunro Kai, Masao Yamaguchi, Mahito Misawa, Yoshihiro Fujimori, Masuji Yamamoto, Hiroshi Hara. (2003) Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. European Journal of Haematology 71:1, 29-38
CrossRef292
U. Aufderhaar, W. Holzgreve, E. Danzer, A. Tichelli, C. Troeger, D. V. Surbek. (2003) The impact of intrapartum factors on umbilical cord blood stem cell banking. Journal of Perinatal Medicine 31:4, 317-322
CrossRef293
Shunro Kai, Hiroshi Hara. (2003) Allogeneic Hematopoietic Stem Cell Transplantation. Therapeutic Apheresis and Dialysis 7:3, 285-291
CrossRef294
Manuel N Fernández, Carmen Regidor, Rafael Cabrera, José A Garcı́a-Marco, Rafael Forés, Isabel Sanjuán, Jorge Gayoso, Santiago Gil, Elena Ruı́z, Ann-Margaret Little, Alasdair McWhinnie, Alejandro Madrigal. (2003) Unrelated umbilical cord blood transplants in adults: Early recoveryof neutrophils by supportive co-transplantation of a low number of highlypurified peripheral blood CD34+ cells from an HLA-haploidentical donor. Experimental Hematology 31:6, 535-544
CrossRef295
Keiichi Isoyama, Kei Ohnuma, Koichiro Ikuta, Yasunori Toyoda, Fumiaki Nakajima, Kouichiro Yamada, Hirokazu Nishihira, . (2003) Unrelated cord blood transplantation for second hemopoietic stem cell transplantation. Pediatrics International 45:3, 268-274
CrossRef296
Fujio Migishima, Atsuhiko Oikawa, Shunzo Kondo, Hideo Ema, Yohei Morita, Hiromitsu Nakauchi, Minesuke Yokoyama, Si-Young Song, Masahiro Nishijima, Masaru Okabe, Nobukata Shinohara. (2003) Full reconstitution of hematopoietic system by murine umbilical cord blood. Transplantation 75:11, 1820-1826
CrossRef297
Hiroyasu Inoue, Yukiharu Yasuda, Kinya Hattori, Takashi Shimizu, Masae Matsumoto, Miharu Yabe, Hiromasa Yabe, Fumiko Tsuchida, Yumiko Tanaka, Gaku Hosoi, Masahiro Sako, Shunichi Kato. (2003) The Kinetics of Immune Reconstitution after Cord Blood Transplantation and Selected cd34+ Stem Cell Transplantation in Children: Comparison with Bone Marrow Transplantation. International Journal of Hematology 77:4, 399-407
CrossRef298
Chatchada Karanes. (2003) Unrelated donor stem cell transplant: donor selection and search process. Pediatric Transplantation 7, 59-64
CrossRef299
Jeffrey M. Lipton. (2003) Peripheral blood as a stem cell source for hematopoietic cell transplantation in children: is the effort in vein?. Pediatric Transplantation 7, 65-70
CrossRef300
Akira Tomonari, Tohru Iseki, Jun Ooi, Satoshi Takahashi, Motohiro Shindo, Koji Ishii, Fumitaka Nagamura, Kaoru Uchimaru, Kenzaburo Tani, Arinobu Tojo, Shigetaka Asano. (2003) Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. British Journal of Haematology 121:2, 304-311
CrossRef301
Scott A. Hagen, Damian M. Craig, Paul L. Martin, Devon D. Plumer, Michael A. Gentile, Scott R. Schulman, Ira M. Cheifetz. (2003) Mechanically ventilated pediatric stem cell transplant recipients: Effect of cord blood transplant and organ dysfunction on outcome. Pediatric Critical Care Medicine 4:2, 206-213
CrossRef302
Peter H. Shaw, Devin Gilligan, Xue-Mei Wang, Peter F. Thall, Seth J. Corey. (2003) Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34+ cells in a closed liquid culture system. Biology of Blood and Marrow Transplantation 9:3, 151-156
CrossRef303
Guillermo F. Sanz, Vanderson Rocha. (2003) Umbilical cord blood transplantation: current status and future directions. Current Opinion in Organ Transplantation 8:1, 109-117
CrossRef304
Kazuta Yasui, Kayoko Matsumoto, Fumiya Hirayama, Yoshihiko Tani, Toru Nakano. (2003) Differences Between Peripheral Blood and Cord Blood in the Kinetics of Lineage-Restricted Hematopoietic Cells: Implications for Delayed Platelet Recovery Following Cord Blood Transplantation. Stem Cells 21:2, 143-151
CrossRef305
Jane L. Liesveld. (2003) When what you have is not enough: optimizing cord blood transplantation in adults. Leukemia Research 27:3, 197-199
CrossRef306
Punit D Wadhwa, Hillard M Lazarus, Omer N Koc, Jennifer Jaroscak, David Woo, Cladd E Stevens, Pablo Rubinstein, Mary J Laughlin. (2003) Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration. Leukemia Research 27:3, 215-220
CrossRef307
Hirokazu Nishihira, Koji Kato, Keiichi Isoyama, Tsuneo A. Takahashi, Shunro Kai, Shunichi Kato, Minoko Takanashi, Norihiro Sato, Hiroyuki Sato, Kohichi Kitajima, Tomoki Naoe, Hidehiko Saito. (2003) The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis. British Journal of Haematology 120:3, 516-522
CrossRef308
Huiying Qiu, Yoshihiro Fujimori, Shunro Kai, Yuka Fujibayashi, Keisuke Nishioka, Hiroshi Hara. (2003) Establishment of Mouse Embryonic Fibroblast Cell Lines That Promote Ex Vivo Expansion of Human Cord Blood CD34+ Hematopoietic Progenitors. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 12:1, 39-46
CrossRef309
Oren M. Tepper, Robert D. Galiano, Christoph Kalka, Geoffrey C. Gurtner. (2003) Endothelial Progenitor Cells: The Promise of Vascular Stem Cells for Plastic Surgery. Plastic and Reconstructive Surgery 111:2, 846-854
CrossRef310
Rainer Storb. (2003) Allogeneic hematopoietic stem cell transplantation—Yesterday, today, and tomorrow. Experimental Hematology 31:1, 1-10
CrossRef311
C.A. Rusinko, D.A. Sesok-Pizzini. (2003) Using a technological community framework to manage new medical technologies: The case of umbilical cord blood (UCB) banking. Journal of Health Organisation and Management 17:6, 399-421
CrossRef312
Muhsi Yang, Tsai-Chi Robert Kuo, Roseanne Murphy Jones. (2003) The marketing strategies analysis for the umbilical cord blood banking service. International Journal of Health Care Quality Assurance 16:6, 293-299
CrossRef313
A. Mastino, C. Favalli, A.R. Camilli, C. Malerba, S. Grelli, A. Calugi. (2003) Umbilical Cord Blood: the Role of Apoptosis in the Control of CD34+ Cell Counts. Placenta 24:1, 113-115
CrossRef314
Mary B. Newman, Cyndy D. Davis, Nicole Kuzmin-Nichols, Paul R. Sanberg. (2003) Human umbilical cord blood (HUCB) cells for central nervous system repair. Neurotoxicity Research 5:5, 355-368
CrossRef315
Young-Ho Lee, Jin-Yeong Han, Su-Yeong Seo, Kyeong-Hee Kim, Young-Ah Lee, Hyung-Sik Lee, Woo-Joo Hur, Hun Han, Hyuk-Chan Kwon, Jae-Seok Kim, Hyo-Jin Kim. (2002) Urokinase could increase the yield of progenitor cells during red cell depletion in elapsed and anticoagulated cord blood. American Journal of Hematology 71:4, 336-339
CrossRef316
Albert Grañena Batista, Christelle Ferra Coll. (2002) Autologous stem cell transplantation and purging in adult acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology 15:4, 675-693
CrossRef317
Suzanne Kadereit, Linda S. Deeds, Stephen E. Haynesworth, Omer N. Koc, Margaret M. Kozik, Emese Szekely, Kathleen Daum‐Woods, Glenn W. Goetchius, Pingfu Fu, Lisbeth A. Welniak, William J. Murphy, Mary J. Laughlin. (2002) Expansion of LTC‐ICs and Maintenance of p21 and BCL‐2 Expression in Cord Blood CD34 + /CD38 − Early Progenitors Cultured over Human MSCs as a Feeder Layer. Stem Cells 20:6, 573-582
CrossRef318
Dorothy E. Vawter, Gayl Rogers-Chrysler, Mary Clay, Larrie Pittelko, Dave Therkelsen, Debora Kim, Jeffrey McCullough. (2002) A phased consent policy for cord blood donation. Transfusion 42:10, 1268-1274
CrossRef319
Hermann Eichler, Christian Beck, Bernd Schroder, Xuan Duc Nguyen, Harald Kluter. (2002) Nonobese diabetic-severe combined immunodeficient mice transplantation of volume-reduced and thawed umbilical cord blood transplants following closed-system immunomagnetic cell selection. Transfusion 42:10, 1285-1292
CrossRef320
Gesine K??gler, Peter G. Middleton, Martina Wilke, Vanderson Rocha, Bennie Esendam, J??rgen Enczmann, Peter Wernet, Eliane Gluckman, Sergio Querol, Lucilla Lecchi, Els Goulmy, Anne M. Dickinson. (2002) Recipient cytokine genotypes for TNF-?? and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation. Transplantation 74:8, 1167-1175
CrossRef321
Cynthia L. Toze, Michael J. Barnett. (2002) Allogeneic haemopoietic stem cell transplantation for non-Hodgkin's lymphoma. Best Practice & Research Clinical Haematology 15:3, 481-504
CrossRef322
Marcos de Lima, Elizabeth J. Shpall. (2002) Cord blood transplantation. Current Opinion in Organ Transplantation 7:3, 286-293
CrossRef323
Paul R. Haut, Lydia Gonzalez-Ryan, Ling-Jia Wang, Marie Olszewski, Elaine Morgan, Morris Kletzel. (2002) Induction of a transient graft vs. leukemia effect following unrelated cord blood transplantation. Pediatric Transplantation 6:4, 348-351
CrossRef324
Hitomi Nagayama, Jun Ooi, Akira Tomonari, Tohru Iseki, Arinobu Tojo, Kenzaburo Tani, Tsuneo A. Takahashi, Naohide Yamashita, Shigetaka Asano. (2002) Severe Immune Dysfunction after Lethal Neutron Irradiation in a JCO Nuclear Facility Accident Victim. International Journal of Hematology 76:2, 157-164
CrossRef325
Jun Ooi, Tohru Iseki, Satoshi Takahashi, Akira Tomonari, Hitomi Nagayama, Koji Ishii, Kiyoshi Ito, Hiroyuki Sato, Tsutomu Takahashi, Motohiro Shindo, Rieko Sekine, Nobuhiro Ohno, Kaoru Uchimaru, Fumitaka Nagamura, Naoki Shirafuji, Arinobu Tojo, Kenzaburo Tani, Shigetaka Asano. (2002) A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. British Journal of Haematology 118:1, 140-143
CrossRef326
Makoto Yazaki, Toshitada Takahashi, Keigo Mizutani, Yasuhiko Ito, Hiroshi Wakiguchi, Masami Inoue, Keisei Kawa, Koji Kato, Toro Kato, Hidehiko Saito, Hajime Togari. (2002) Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantation. British Journal of Haematology 117:4, 893-898
CrossRef327
R. Haase, P. Wiegand, W. Hirsch, A. Meyer-Bahlburg, X. Diwan, A. Wawer, S. Burdach. (2002) Unusual presentation of central nervous system relapse with oculomotor nerve palsy in a case of CD56-positive acute myeloid leukemia following allogeneic stem cell transplantation. Pediatric Transplantation 6:3, 260-265
CrossRef328
Alois Gratwohl, Jakob Passweg, Helen Baldomero, Bruno Horisberger, Alvaro Urbano-Ispizua, . (2002) Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. British Journal of Haematology 117:2, 451-468
CrossRef329
Norbert-Claude Gorin, Steven Piantadosi, Margaret Stull, Helene Bonte, John R. Wingard, Curt Civin. (2002) Increased Risk of Lethal Graft-Versus-Host Disease-like Syndrome after Transplantation into NOD/SCID Mice of Human Mobilized Peripheral Blood Stem Cells, As Compared to Bone Marrow or Cord Blood. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 11:2, 277-292
CrossRef330
Eleanor Rainsford, Denis J. Reen. (2002) Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. British Journal of Haematology 116:3, 702-709
CrossRef331
Marie-Térèse Little, Rainer Storb. (2002) History of haematopoietic stem-cell transplantation. Nature Reviews Cancer 2:3, 231-238
CrossRef332
Juliet N. Barker, John E. Wagner. (2002) Umbilical cord blood transplantation: current state of the art. Current Opinion in Oncology 14:2, 160-164
CrossRef333
Rosemary L. Sparrow, Jennifer A. Cauchi, Lanny T. Ramadi, Caryll M. Waugh, Mark A. Kirkland. (2002) Influence of mode of birth and collection on WBC yields of umbilical cord blood units. Transfusion 42:2, 210-215
CrossRef334
Alois Gratwohl. (2002) The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation. International Journal of Hematology 76:S1, 386-392
CrossRef335
Eiichi Azuma, Masahiro Hirayama, Hatsumi Yamamoto, Yoshihiro Komada. (2002) The Role of Donor Age in Naive T-cell Recovery Following Allogeneic Hematopoietic Stem Cell Transplantation: The Younger the Better. Leukemia & Lymphoma 43:4, 735-739
CrossRef336
Norbert Schmitz, John Barrett. (2002) Optimizing engraftment-source and dose of stem cells. Seminars in Hematology 39:1, 3-14
CrossRef337
Keren Osman, Raymond L. Comenzo. 2002. Stem Cell Transplantation. , 253-263.
CrossRef338
Yuka Hirose, Hitoshi Kiyoi, Katsuhiko Itoh, Koji Kato, Hidehiko Saito, Tomoki Naoe. (2001) B-cell precursors differentiated from cord blood CD34+ cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cells. Immunology 104:4, 410-417
CrossRef339
P.Jean Henslee-Downey. (2001) Allogeneic transplantation across major HLA barriers. Best Practice & Research Clinical Haematology 14:4, 741-754
CrossRef340
Ya-Chien Yang, Tsuey-Ying Hsu, Jen-Yang Chen, Czau-Siung Yang, Rong-Hwa Lin. (2001) Tumour necrosis factor-alpha-induced apoptosis in cord blood T lymphocytes: involvement of both tumour necrosis factor receptor types 1 and 2. British Journal of Haematology 115:2, 435-441
CrossRef341
Thomas G. Gross, R. Maarten Egeler, Franklin O. Smith. (2001) PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. Hematology/Oncology Clinics of North America 15:5, 795-808
CrossRef342
Akihiko Nomura, Hidetoshi Takada, Cheng-Hao Jin, Tamami Tanaka, Shouichi Ohga, Toshiro Hara. (2001) Functional analyses of cord blood natural killer cells and T cells. Experimental Hematology 29:10, 1169-1176
CrossRef343
Hideaki Ohta, Ji Yoo Kim, Akihisa Sawada, Sadao Tokimasa, Hiroyuki Fujisaki, Yoshiko Matsuda, Yuko Osugi, Junichi Hara. (2001) Second Transplantation With CD34+ Blood Cells From an HLA-Mismatched Related Donor After Engraftment Failure of Transplanted Cord Blood Cells. International Journal of Hematology 74:3, 338-341
CrossRef344
Kenneth I. Weinberg, Neena Kapoor, Ami J. Shah, Gay M. Crooks, Donald B. Kohn, Robertson Parkman. (2001) Hematopoietic stem cell transplantation for severe combined immune deficiency. Current Allergy and Asthma Reports 1:5, 416-420
CrossRef345
Jun Ooi, Tohru Iseki, Hitomi Nagayama, Akira Tomonari, Kiyoshi Ito, Naoki Shirafuji, Arinobu Tojo, Kenzaburo Tani, Shigetaka Asano. (2001) Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia. British Journal of Haematology 114:4, 834-836
CrossRef346
G.J. Madlambayan, I. Rogers, R.F. Casper, P.W. Zandstra. (2001) Controlling Culture Dynamics for the Expansion of Hematopoietic Stem Cells. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 10:4, 481-492
CrossRef347
Rafael Bornstein, Jose Garcia-Vela, Florinda Gilsanz, Claude Auray, Carmela Cales. (2001) Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. British Journal of Haematology 114:2, 458-465
CrossRef348
Yasuo Tokushima, Norihisa Sasayama, Tsuneo A. Takahashi. (2001) Repopulating activities of human cord blood cells separated by a stem cell collection filter in NOD/SCID mice:a comparative study of filter method and HES method. Transfusion 41:8, 1014-1019
CrossRef349
Z Brahmi, G Hommel-Berrey, F Smith, B Thomson. (2001) NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Human Immunology 62:8, 782-790
CrossRef350
Tim Niehues, Vanderson Rocha, Alexandra H. Filipovich, Ka Wah Chan, Raphael Porcher, Gerard Michel, Juan J. Ortega, Peter Wernet, Ulrich Gobel, Eliane Gluckman, Franco Locatelli. (2001) Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis. British Journal of Haematology 114:1, 42-48
CrossRef351
Jeffrey McCullough. (2001) Cellular engineering for the production of blood components. Transfusion 41:7, 853-856
CrossRef352
Karen K. Ballen, Helen Valinski, Dale Greiner, Leonard D. Shultz, Pamela S. Becker, Chung Cheng Hsieh, F. Marc Stewart, Peter J. Quesenberry. (2001) Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic-severe combined immunodeficient assay. British Journal of Haematology 114:1, 211-218
CrossRef353
Gluckman, Eliane, . (2001) Hematopoietic Stem-Cell Transplants Using Umbilical-Cord Blood. New England Journal of Medicine 344:24, 1860-1861
Full Text354
Barker, J.N., Weisdorf, D.J., Wagner, J.E., . (2001) Creation of a Double Chimera after the Transplantation of Umbilical-Cord Blood from Two Partially Matched Unrelated Donors. New England Journal of Medicine 344:24, 1870-1871
Full Text355
Laughlin, Mary J., Barker, Juliet, Bambach, Barbara, Koc, Omer N., Rizzieri, David A., Wagner, John E., Gerson, Stanton L., Lazarus, Hillard M., Cairo, Mitchell, Stevens, Cladd E., Rubinstein, Pablo, Kurtzberg, Joanne, . (2001) Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors. New England Journal of Medicine 344:24, 1815-1822
Full Text356
Eliane Gluckman, Vanderson Rocha, Sylvie Chevret. (2001) RESULTS OF UNRELATED UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELL TRANSPLANTATION. Reviews in Clinical and Experimental Hematology 5:2, 87-99
CrossRef357
Peter H. Shaw, Marie Olszewski, Morris Kletzel. (2001) Expansion of Megakaryocyte Precursors and Stem Cells from Umbilical Cord Blood CD34+ Cells in Collagen and Liquid Culture Media. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 10:3, 391-403
CrossRef358
Kyung-Ha Ryu, Susan Chun, Steve Carbonierre, Seock-Ah Im, Hyung-Lae Kim, Myeong Heon Shin, Hee-Young Shin, Hyo-Seop Ahn, So-Youn Woo, Ju-Young Seoh, John K. Fraser. (2001) Apoptosis and megakaryocytic differentiation during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. British Journal of Haematology 113:2, 470-478
CrossRef359
S. Stanworth, R. Warwick, D. Fehily, C. Persaud, S. Armitage, C. Navarrete, M. Contreras. (2001) An international survey of unrelated umbilical cord blood banking. Vox Sanguinis 80:4, 236-243
CrossRef360
Andrew L. Pecora. (2001) Progress in clinical application of use of progenitor cells expanded with hematopoietic growth factors. Current Opinion in Hematology 8:3, 142-148
CrossRef361
E.A de Wynter, N.G Testa. (2001) Interest of cord blood stem cells. Biomedicine & Pharmacotherapy 55:4, 195-200
CrossRef362
Lucilla Lecchi, Paolo Rebulla, Ilaria Ratti, Mara Magri, Filomena Garcea, Francesca Marangoni, Tommaso Bertele, Rosaria Giordano, Girolamo Sirchia. (2001) Outcomes of a program to evaluate mother and baby 6 months after umbilical cord blood donation. Transfusion 41:5, 606-610
CrossRef363
Stephen R. Munzer, Franklin O. Smith. (2001) Limited Property Rights in Umbilical Cord Blood for Transplantation and Research. Journal of Pediatric Hematology/Oncology 23:4, 203-207
CrossRef364
F.Y. Lau, R. Wong, C.H. Chui, G. Cheng. (2001) Successful Engraftment in Two Adult Patients with Severe Aplastic Anemia Using Nonmyeloablative Conditioning Followed by Unrelated HLA-Mismatched Cord Blood Transplantation. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 10:2, 309-311
CrossRef365
Carolyn C. Hoppe, Mark C. Walters. (2001) Bone marrow transplantation in sickle cell anemia. Current Opinion in Oncology 13:2, 85-90
CrossRef366
Kam S. Tsang, Karen Li, Dolly P. Huang, Angela P. Wong, Yonna Leung, Tai T. Lau, Allan M.Z. Chang, Chi K. Li, Tai F. Fok, Patrick M.P. Yuen. (2001) Dextran sedimentation in a semi-closed system for the clinical banking of umbilical cord blood. Transfusion 41:3, 344-352
CrossRef367
Kei Ohnuma, Keiichi Isoyama, Koichiro Ikuta, Yasunori Toyoda, Junko Nakamura, Fumiaki Nakajima, Masahiro Tsuchida, Mutsuro Ohira, Aiko Suminoe, Toshiro Hara, Hirokazu Nishihira. (2001) Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies. British Journal of Haematology 112:4, 981-987
CrossRef368
Annette Luther-Wyrsch, Eithne Costello, Markus Thali, Elena Buetti, Catherine Nissen, Daniel Surbek, Wolfgang Holzgreve, Alois Gratwohl, André Tichelli, Aleksandra Wodnar-Filipowicz. (2001) Stable Transduction with Lentiviral Vectors and Amplification of Immature Hematopoietic Progenitors from Cord Blood of Preterm Human Fetuses. Human Gene Therapy 12:4, 377-389
CrossRef369
Thomas G. Martin, James L. Gajewski. (2001) Allogeneic Stem Cell Transplantation for Acute Lymphocytic Leukemia in Adults. Hematology/Oncology Clinics of North America 15:1, 97-120
CrossRef370
Lorenza Lazzari, Simona Lucchi, Paolo Rebulla, Laura Porretti, Giuseppe Puglisi, Lucilla Lecchi, Girolamo Sirchia. (2001) Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. British Journal of Haematology 112:2, 397-404
CrossRef371
I. Varis, V. Deneys, A.M. Mazzon, M. De Bruyere, G. Cornu, B. Brichard. (2001) Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytes. European Journal of Haematology 66:2, 107-114
CrossRef372
Ruiling Xu, Jo Anna Reems. (2001) Umbilical cord blood progeny cells that retaina CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells. Transfusion 41:2, 213-218
CrossRef373
Guillermo Garcia-Manero, Deborah A. Thomas. (2001) Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia. Hematology/Oncology Clinics of North America 15:1, 163-205
CrossRef374
Franklin O. Smith, Blythe G. Thomson, Hal E. Broxmeyer. (2000) Umbilical cord blood transplantation. Current Opinion in Organ Transplantation 5:4, 358-365
CrossRef375
L. Dal Cortivo, I. Robert, C. Mangin, T. Sameshima, S. Kora, E. Gluckman, M. Benbunan, J.P. Marolleau. (2000) Cord Blood Banking: Volume Reduction Using "Procord" Terumo Filter. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 9:6, 885-890
CrossRef376
Pablo Rubinstein, Cladd E. Stevens. (2000) Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Best Practice & Research Clinical Haematology 13:4, 565-584
CrossRef377
Masahiro Hirayama, Eiichi Azuma, Qi Jiang, Michihiro Kobayashi, Shotaro Iwamoto, Tadashi Kumamoto, Rodrick Kisenge, Hatsumi Yamamoto, Yoshihiro Komada. (2000) The reconstitution of CD45RBhiCD4+ naive T cells is inversely correlated with donor age in murine allogeneic haematopoietic stem cell transplantation. British Journal of Haematology 111:2, 700-707
CrossRef378
Ruiling Xu, Michael Medchill, Jo Anna Reems. (2000) Serum supplement, inoculum cell density, and accessory cell effects are dependent on the cytokine combination selected to expand human HPCs ex vivo. Transfusion 40:11, 1299-1307
CrossRef379
Ian McNiece, Dax Kubegov, Patrick Kerzic, Elizabeth J Shpall, Sherilyn Gross. (2000) Increased expansion and differentiation of cord blood products using a two-step expansion culture. Experimental Hematology 28:10, 1181-1186
CrossRef380
Philippe Guardiola, Mathieu Kuentz, Frederic Garban, Didier Blaise, Josy Reiffers, Michel Attal, Agnes Buzyn, Bruno Lioure, Pierre Bordigoni, Nathalie Fegueux, Marie-Laure Tanguy, Jean-Paul Vernant, Eliane Gluckman, Gerard Socie, . (2000) Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. British Journal of Haematology 111:1, 292-302
CrossRef381
Lia Gore, Peter A. Lane, Ralph R. Quinones, Roger H. Giller. (2000) Successful Cord Blood Transplantation for Sickle Cell Anemia From a Sibling Who Is Human Leukocyte Antigen-Identical: Implications for Comprehensive Care. Journal of Pediatric Hematology/Oncology 22:5, 437-440
CrossRef382
Hermann Eichler, Thomas Schaible, Ekkehard Richter, Wolfgang Zieger, Katrin Voller, Andreas Leveringhaus, Shraga F. Goldmann. (2000) Cord blood as a source of autologous RBCs for transfusion to preterm infants. Transfusion 40:9, 1111-1117
CrossRef383
Sonja van den Oudenrijn, Albert E.G.K von dem Borne, Masja de Haas. (2000) Differences in megakaryocyte expansion potential between CD34+ stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Experimental Hematology 28:9, 1054-1061
CrossRef384
Shara B.A Cohen, Xiao Nong Wang, Anne Dickinson. (2000) Can cord blood cells support the cytokine storm in GvHD?. Cytokine & Growth Factor Reviews 11:3, 185-197
CrossRef385
A. Suarez, L. Mozo, A. Gayo, A. Simo, C. Gutierrez. (2000) Induction of functional CD154 (CD40 ligand) in neonatal T cells by cAMP-elevating agents. Immunology 100:4, 432-440
CrossRef386
Kei Ohnuma, Keiichi Isoyama, Koichiro Ikuta, Yasunori Toyoda, Junko Nakamura, Fumiaki Nakajima, Hirokazu Nishihira. (2000) The Influence of HLA Genotyping Compatibility on Clinical Outcome after Cord Blood Transplantation from Unrelated Donors. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 9:4, 541-550
CrossRef387
S. Rendine, E.S. Curtoni, P. Francia di Celle, M. Berrino, L. Bertola, M. Barbanti, P. Saracco, L. Fazio, E. Gay, A.M. Dall'Omo. (2000) Analysis of the Turin Umbilical Cord Blood Bank Registry. Transfusion 40:7, 813-816
CrossRef388
D.V. Surbek, W. Holzgreve, C. Steinmann, S. Hahn, A. Gratwohl, A. Wodnar-Filipowicz, A. Tichelli. (2000) Preterm birth and the availability of cord blood for HPC transplantation. Transfusion 40:7, 817-820
CrossRef389
Ornella Belvedere, Cristina Feruglio, Walter Malangone, Maria L. Bonora, Alessandro M. Minisini, Riccardo Spizzo, Annibale Donini, Pierguido Sala, Dino De Anna, David M. Hilbert, Alberto Degrassi. (2000) Increased Blood Volume and CD34 + CD38 − Progenitor Cell Recovery Using a Novel Umbilical Cord Blood Collection System. Stem Cells 18:4, 245-251
CrossRef390
Rocha, Vanderson, Wagner, John E. Jr., Sobocinski, Kathleen A., Klein, John P., Zhang, Mei-Jie, Horowitz, Mary M., Gluckman, Eliane, . (2000) Graft-Versus-Host Disease in Children Who Have Received a Cord-Blood or Bone Marrow Transplant from an HLA-Identical Sibling. New England Journal of Medicine 342:25, 1846-1854
Full Text391
S. Querol, G. Capmany, C. Azqueta, M. Gabarro, O. Fornas, G.A. Martin-Henao, J. Garcia. (2000) Direct immunomagnetic method for CD34+ cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols. Transfusion 40:6, 625-631
CrossRef392
Toyoaki Murohara, Hisao Ikeda, Junli Duan, Satoshi Shintani, Ken-ichiro Sasaki, Hiroyuki Eguchi, Ichiro Onitsuka, Kazuo Matsui, Tsutomu Imaizumi. (2000) Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization. Journal of Clinical Investigation 105:11, 1527-1536
CrossRef393
Franklin O Smith, Blythe G Thomson. (2000) Umbilical Cord Blood Collection, Banking, and Transplantation: Current Status and Issues Relevant to Perinatal Caregivers. Birth 27:2, 127-135
CrossRef394
Avi Tsafrir, Chaim Brautbar, Arnon Nagler, Uriel Elchalal, Keren Miller, Amal Bishara. (2000) Alloreactivity of umbilical cord blood mononuclear cells: specific hyporesponse to noninherited maternal antigens. Human Immunology 61:6, 548-554
CrossRef395
ANTONELLA GASPARONI, LAURA CIARDELLI, MARIA ANTONIA AVANZINI, MAURIZIO BONFICHI, MARCO DI MARIO, GAIA PIAZZI, LUCIA MARTINOTTI, LAURA VANELLI, GIORGIO RONDINI, GAETANO CHIRICO. (2000) Immunophenotypic Changes of Fetal Cord Blood Hematopoietic Progenitor Cells During Gestation. Pediatric Research 47:6, 825-829
CrossRef396
Sachiyo Kanamaru, Yoshifumi Kawano, Tsutomu Watanabe, Ryuji Nakagawa, Hiroko Suzuya, Toshihiro Onishi, Jun Yamazaki, Takayoshi Nakayama, Yasuhiro Kuroda, Yoichi Takaue. (2000) Low Numbers of Megakaryocyte Progenitors in Grafts of Cord Blood Cells May Result in Delayed Platelet Recovery After Cord Blood Cell Transplant. Stem Cells 18:3, 190-195
CrossRef397
Alison M. Rice, Julie A. Wood, Christopher G. Milross, Cathryn J. Collins, Nigel F. McCarthy, Marcus R. Vowels. (2000) CONDITIONS THAT ENABLE HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT IN ALL NOD-SCID MICE1. Transplantation927-935
CrossRef398
Eric M Mickelson, Effie Petersdorf, Claudio Anasetti, Paul Martin, Ann Woolfrey, John A Hansen. (2000) HLA matching in hematopoietic cell transplantation. Human Immunology 61:2, 92-100
CrossRef399
Deborah Rund, Eliezer Rachmilewitz. (2000) New trends in the treatment of β-thalassemia. Critical Reviews in Oncology/Hematology 33:2, 105-118
CrossRef400
Uriel Elchalal, Sozos J. Fasouliotis, David Shtockheim, Chaim Brautbar, Joseph G. Schenker, Daniel Weinstein, Arnon Nagler. (2000) Postpartum umbilical cord blood collection for transplantation: A comparison of three methods. American Journal of Obstetrics and Gynecology 182:1, 227-232
CrossRef401
I.L. Barbosa, M.E. Sousa, M.I. Godinho, F. Sousa, A. Carvalhais. (1999) Single- versus dual-platform assays for human CD34+ cell enumeration. Cytometry 38:6, 274-279
CrossRef402
Mark C. Walters. (1999) Bone Marrow Transplantation for Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 21:6, 467-474
CrossRef403
Peter H. Shaw, Paul R. Haut, Marie Olszewski, Morris Kletzel. (1999) Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: One center’s experience. Pediatric Transplantation 3:4, 315-321
CrossRef404
K. Yong, A. Fahey, L. Reeve, C. Nicholls, N. S. B. Thomas, A. Pizzey, S. J. Ings, M. J. Watts, D. C. Linch. (1999) Cord blood progenitor cells have greater transendothelial migratory activity and increased responses to SDF-1 and MIP-3beta compared with mobilized adult progenitor cells. British Journal of Haematology 107:2, 441-449
CrossRef405
P. Jean Henslee-Downey, Elaine Gluckman. (1999) ALLOGENEIC TRANSPLANTATION FROM DONORS OTHER THAN HLA-IDENTICAL SIBLINGS. Hematology/Oncology Clinics of North America 13:5, 1017-1039
CrossRef406
Mary E.D. Flowers, Emin Kansu, Keith M. Sullivan. (1999) PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE. Hematology/Oncology Clinics of North America 13:5, 1091-1112
CrossRef407
Effie W Petersdorf, Eric M Mickelson, Claudio Anasetti, Paul J Martin, Ann E Woolfrey, John A Hansen. (1999) Effect of HLA mismatches on the outcome of hematopoietic transplants. Current Opinion in Immunology 11:5, 521-526
CrossRef408
Wing Leung, Manuel Ram??rez, Goutam Mukherjee, Elizabeth J. Perlman, Curt I. Civin. (1999) COMPARISONS OF ALLOREACTIVE POTENTIAL OF CLINICAL HEMATOPOIETIC GRAFTS1. Transplantation 68:5, 628-635
CrossRef409
M. Boeckh. (1999) Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy. Transplant Infectious Disease 1:3, 165-178
CrossRef410
Michael Potter. (1999) New anti-cancer therapies, new opportunities for infection. Current Opinion in Infectious Diseases 12:4, 359-363
CrossRef411
Giovanni D'Arena, Pellegrino Musto, Nicola Cascavilla, Maria Marta Minervini, Girolamo Di Giorgio, Annamaria Maglione, Mario Carotenuto. (1999) Inability of Activated Cord Blood T Lymphocytes to Perform Th1-like and Th2-like Responses: Implications for Transplantation. Journal of Hematotherapy <html_ent glyph="@amp;" ascii="&"/> Stem Cell Research 8:4, 381-385
CrossRef412
Qi Sun, Robert L. Burton, Karen E. Pollok, David J. Emanuel, Kenneth G. Lucas. (1999) CD4+ Epstein–Barr Virus-Specific Cytotoxic T-Lymphocytes from Human Umbilical Cord Blood. Cellular Immunology 195:2, 81-88
CrossRef413
AI GUO WU, MARIA MICHEJDA, AMITABHA MAZUMDER, KENNETH R. MEEHAN, FREDERICK A. MENENDEZ, JEAN-GILLES TCHABO, REBECCA SLACK, MARK P. JOHNSON, JOSEPH A. BELLANTI. (1999) Analysis and Characterization of Hematopoietic Progenitor Cells from Fetal Bone Marrow, Adult Bone Marrow, Peripheral Blood, and Cord Blood. Pediatric Research 46:2, 163-169
CrossRef414
Socié, Gérard, Stone, Judith Veum, Wingard, John R., Weisdorf, Daniel, Henslee-Downey, P. Jean, Bredeson, Christopher, Cahn, Jean-Yves, Passweg, Jakob R., Rowlings, Philip A., Schouten, Harry C., Kolb, Hans-Jochem, Bender-Götze, Christine, Camitta, Bruce M., Godder, Kamar, Horowitz, Mary M., Wayne, Alan S., Klein, John P., . (1999) Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation. New England Journal of Medicine 341:1, 14-21
Full Text415
Lidia De Felice, Tiziana Di Pucchio, Maria Grazia Mascolo, Francesca Agostini, Massimo Breccia, Cesare Guglielmi, Maria Rosaria Ricciardi, Agostino Tafuri, Maria Screnci, Franco Mandelli, William Arcese. (1999) Flt3L induces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures. British Journal of Haematology 106:1, 133-141
CrossRef416
A El Ghalbzouri, B Drénou, V Blancheteau, C Choqueux, R Fauchet, D Charron, N Mooney. (1999) An in vitro model of allogeneic stimulation of cord blood. Human Immunology 60:7, 598-607
CrossRef417
Craig Donaldson, W. John Armitage, Val Laundy, Clive Barron, Ruth Buchanan, Jill Webster, Ben Bradley, Jill Hows. (1999) Impact of obstetric factors on cord blood donation for transplantation. British Journal of Haematology 106:1, 128-132
CrossRef418
G. Sirchia, P. Rebulla, S. Tibaldi, L. Lecchi. (1999) Cost of umbilical cord blood units released for transplantation. Transfusion 39:6, 645-650
CrossRef419
Dean A. Follmann, Paul S. Albert. (1999) Bayesian Monitoring of Event Rates with Censored Data. Biometrics 55:2, 603-607
CrossRef420
P. A. Denning-Kendall, H. Horsley, C. Donaldson, B. Bradley, J. M. Hows. (1999) Different behaviour of fresh and cultured CD34+ cells during immunomagnetic separation. British Journal of Haematology 105:3, 780-785
CrossRef421
Paolo Perutelli, Silvia Catellani, Lucia Scarso, Paolo Cornaglia-Ferraris, Giorgio Dini. (1999) Processing of Human Cord Blood by Three Different Procedures for Red Blood Cell Depletion and Mononuclear Cell Recovery. Vox Sanguinis 76:4, 237-240
CrossRef422
Memet Aker, Gabor Varadi, Shimon Slavin, Arnon Nagler. (1999) Fludarabine-Based Protocol for Human Umbilical Cord Blood Transplantation in Children With Fanconi Anemia. Journal of Pediatric Hematology/Oncology 21:3, 237-239
CrossRef423
E. Donnall Thomas. (1999) A history of haemopoietic cell transplantation. British Journal of Haematology 105:2, 330-339
CrossRef424
Alan P. Knutsen, Donna A. Wall. (1999) Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. Journal of Allergy and Clinical Immunology 103:5, 823-832
CrossRef425
Jo Anna Reems, Deanna Fujita, Tom Tyler, Richard Moldwin, Stephen Smith. (1999) Obtaining an accepted Investigational New Drug application to operate an umbilical cord blood bank. Transfusion 39:4, 357-363
CrossRef426
Carolyn Katovich Hurley, Judith A Wade, Machteld Oudshoorn, Derek Middleton, Debra Kukuruga, Cristina Navarrete, Frank Christiansen, Janet Hegland, Ee-Chee Ren, Irene Andersen, Susan A Cleaver, Chaim Brautbar, Colette Raffoux. (1999) A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Human Immunology 60:4, 347-360
CrossRef427
R. HANDGRETINGER, M. SCHUMM, P. LANG, J. GREIL, A. REITER, P. BADER, D. NIETHAMMER, T. KLINGEBIEL. (1999) Transplantation of Megadoses of Purified Haploidentical Stem Cells. Annals of the New York Academy of Sciences 872:1 HEMATOPOIETIC, 351-362
CrossRef428
Leigh C. Jefferies, Mary Albertus, Mark A. Morgan, David Moolten. (1999) High deferral rate for maternal-neonatal donor pairs for an allogeneic umbilical cord blood bank. Transfusion 39:4, 415-419
CrossRef429
Heike Engel, Ergul Kaya, Rainer Bald, Hannelore Kolhagen, Ottilia Grecu, Thomas Schondorf, Ursula Brenne, Christian M. Kurbacher, Uwe J. Gohring, Markus Kleine, Peter Mallmann. (1999) Fetal Cord Blood as an Alternative Source of Hematopoietic Progenitor Cells: Immunophenotype, Maternal Cell Contamination, and Ex Vivo Expansion. Journal of Hematotherapy 8:2, 141-155
CrossRef430
Veronique Conrad, Maryse Dupouy, Laurence Bordenave, Francis Lacombe, Charles Baquey, Josy Reiffers, Jean Ripoche. (1999) Expansion and differentiation of haemopoietic progenitor cells on endothelialized hydroxyapatite under static conditions. British Journal of Haematology 105:1, 40-49
CrossRef431
PABLO RUBINSTEIN, JOHN W. ADAMSON, CLADD STEVENS. (1999) The Placental/Umbilical Cord Blood Program of the New York Blood Center A Progress Report. Annals of the New York Academy of Sciences 872:1 HEMATOPOIETIC, 328-335
CrossRef432
Giuseppe Cimino, Maria Cristina Rapanotti, Loredana Elia, Anna Paola Iori, Cesare Guglielmi, Maria Screnci, Daniela Carmini, Lidia De Felice, Maria Luisa Moleti, Andrea Mengarelli, Franco Mandelli, William Arcese. (1999) A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. British Journal of Haematology 104:4, 770-777
CrossRef433
Kim Theilgaard-Mönch, Klas Raaschou-Jensen, Carsten Heilmann, Helle Andersen, Johannes Bock, Charlotte A. Russel, Lars Vindeløv, Niels Jacobsen, Ebbe Dickmeiss. (1999) A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts. European Journal of Haematology 62:3, 174-183
CrossRef434
Buckley, Rebecca H., Schiff, Sherrie E., Schiff, Richard I., Markert, M. Louise, Williams, Larry W., Roberts, Joseph L., Myers, Laurie A., Ward, Frances E., . (1999) Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency. New England Journal of Medicine 340:7, 508-516
Full Text435
Carmen Regidor, Manuel Posada, Dolores Monteagudo, Carlos Garaulet, Nieves Somolinos, Rafael Forés, Montserrat Briz, Manuel-Nicolás Fernández. (1999) Umbilical cord blood banking for unrelated transplantation. Experimental Hematology 27:2, 380-385
CrossRef436
T. Köhler, R. Plettig, W. Wetzstein, B. Schaffer, R. Ordemann, H.‐O. Nagels, G. Ehninger, M. Bornhäuser. (1999) Defining Optimum Conditions for the Ex Vivo Expansion of Human Umbilical Cord Blood Cells. Influences of Progenitor Enrichment, Interference with Feeder Layers, Early‐Acting Cytokines and Agitation of Culture Vessels. Stem Cells 17:1, 19-24
CrossRef437
C.M Craven, K Ward. (1999) Transfusion of fetal cord blood cells: An improved method of hematopoietic stem cell transplantation?. Journal of Reproductive Immunology 42:1, 59-77
CrossRef438
JOHN K. FRASER, MITCHELL S. CAIRO, ELIZABETH L. WAGNER, PAUL R. McCURDY, LEE ANN BAXTER-LOWE, SHELLY L. CARTER, NANCY A. KERNAN, MICHAEL C. LILL, VICTORIA SLONE, JOHN E. WAGNER, CHARLES H. WALLAS, JOANNE KURTZBERG. (1998) Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures. Journal of Hematotherapy 7:6, 521-561
CrossRef439
Hal E. Broxmeyer. (1998) Cord Blood Transplantation Study Standard Operating Procedures: An Evolving Document Will Improve Cord Blood Unit Quality. Journal of Hematotherapy 7:6, 479-480
CrossRef440
Marjorie Pick, Arnon Nagler, Dan Grisaru, Amiram Eldor, Varda Deutsch. (1998) Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure. British Journal of Haematology 103:3, 639-650
CrossRef441
Shlebak, Roberts, Stevens, Syzdlo, Goldman, Gordon. (1998) The impact of antenatal and perinatal variables on cord blood haemopoietic stem/progenitor cell yield available for transplantation. British Journal of Haematology 103:4, 1167-1171
CrossRef442
Rubinstein, Pablo, Carrier, Carmelita, Scaradavou, Andromachi, Kurtzberg, Joanne, Adamson, John, Migliaccio, Anna Ritá, Berkowitz, Richard L., Cabbad, Michael, Dobrila, N. Ludy, Taylor, Patricia E., Rosenfield, Richard E., Stevens, Cladd E., . (1998) Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors. New England Journal of Medicine 339:22, 1565-1577
Full Text443
Parkman, Robertson, . (1998) The Future of Placental-Blood Transplantation. New England Journal of Medicine 339:22, 1628-1629
Full Text444
DRE Jones. (1998) The prospects for in utero stem cell transplantation. Expert Opinion on Investigational Drugs 7:11, 1819-1824
CrossRef445
Daniel V. Surbek, Wolfgang Holzgreve, Wendy Jansen, Doris Heim, Henk Garritsen, Catherine Nissen, Aleksandra Wodnar-Filipowicz. (1998) Quantitative immunophenotypic characterization, cryopreservation, and enrichment of second- and third-trimester human fetal cord blood hematopoietic stem cells (progenitor cells). American Journal of Obstetrics and Gynecology 179:5, 1228-1233
CrossRef446
IAN K. McNIECE, GREGORY B. STONEY, BRENT P. KERN, ROBERT A. BRIDDELL. (1998) CD34+ Cell Selection from Frozen Cord Blood Products Using the Isolex 300i and CliniMACS CD34 Selection Devices. Journal of Hematotherapy 7:5, 457-461
CrossRef447
Cristina Navarrete, Ruth Warwick, Deirdre Fehily, Marcela Contreras. (1998) Use of Cord Blood Progenitor Cells as an Alternative for Bone Marrow Transplantation. Vox Sanguinis 75:2, 167-170
CrossRef448
Tim M. Opie, Laurence E. Shields, Robert G. Andrews. (1998) Cell‐Surface Antigen Expression in Early and Term Gestation Fetal Hematopoietic Progenitor Cells. Stem Cells 16:5, 343-348
CrossRef449
Yu-Lung Lau, Edmond S. K. Ma, Shau-Yin Ha, Godfrey C. F. Chan, David Chiu, Mary Tang, Brian R. Hawkins, Vivian Chan, Raymond H. S. Liang. (1998) Sibling HLA-Matched Cord Blood Transplant for p-Thalassemia. Journal of Pediatric Hematology/Oncology 20:5, 477-481
CrossRef450
Wood, Alastair J.J., , Pui, Ching-Hon, Evans, William E., . (1998) Acute Lymphoblastic Leukemia. New England Journal of Medicine 339:9, 605-615
Full Text451
JEREMY SUGARMAN, LYLA KAPLAN, BETTY COGSWELL, JANICE OLSON. (1998) Pregnant Women's Perspectives on Umbilical Cord Blood Banking. Journal of Women's Health 7:6, 747-757
CrossRef452
Franco Locatelli. (1998) The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation. British Journal of Haematology 102:3, 633-638
CrossRef453
E. Gluckman, V. Rocha, C. Chastang, . (1998) Cord Blood Banking and Transplant in Europe. Vox Sanguinis 74:S2, 95-101
CrossRef454
Joseph Kapelushnik, Gabor Varadi, Arron Nagler. (1998) Matched Unrelated Human Umbilical Cord Blood Transplantation for X-Linked Adrenoleukodystrophy. Journal of Pediatric Hematology/Oncology 20:3, 257-259
CrossRef455
Susumu Inoue. (1998) Cord blood transplant: Current and future issues. The Indian Journal of Pediatrics 65:2, 163-171
CrossRef456
Fabio Timeus, Nicoletta Crescenzio, Giuseppe Basso, Ugo Ramenghi, Paola Saracco, Vilma Gabutti. (1998) Cell Adhesion Molecule Expression in Cord Blood CD34 + Cells. Stem Cells 16:2, 120-126
CrossRef457
C Rozman, J Sierra. (1997) The periphery is now central. The Lancet 350, SIII9
CrossRef
